[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f4DDrfZaUaT__SMnluqRkr0T5PjdG46dmfyK9QXTyGFc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":84,"rows":91},"Taipei Veterans General Hospital, Taiwan",[4],326,false,44,14,223243,21,217,[14,17,20,22,25,27,29,31],{"name":15,"count":16},"Hepatocellular Carcinoma",9,{"name":18,"count":19},"Type 2 Diabetes",7,{"name":21,"count":19},"Stroke",{"name":23,"count":24},"Adhesive Capsulitis",6,{"name":26,"count":24},"Parkinson Disease",{"name":28,"count":24},"Dry Eye Syndrome",{"name":30,"count":24},"Anesthesia",{"name":32,"count":33},"Hypertension",4,[35,40,45,50,55,60,65,70,74,79],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05017402","Higher Dose of Alglucosidase Alpha for Pompe Disease","2023-12-31","Alglucosidase Alfa",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT06503172","Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level","2024-12","Taiwanese whole grain job's tear",{"nctId":46,"briefTitle":47,"date":48,"intervention":49},"NCT06771427","Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome","2025-04-30","Chinese herbal tea TBDESJS",{"nctId":51,"briefTitle":52,"date":53,"intervention":54},"NCT07017894","Applying Breast Mask Containing Cabbage Leaves Extract to Relieve Breast Discomfort in Breastfeeding Women","2025-07-01","Experimental: breast mask containing cabbage leaves extract group",{"nctId":56,"briefTitle":57,"date":58,"intervention":59},"NCT06997289","Intelligent Approach to Traditional Chinese Medicine for Insomnia","2025-12-19","Group that is receiving treatment.",{"nctId":61,"briefTitle":62,"date":63,"intervention":64},"NCT06700681","RCT Comparing Remimazolam With Propofol Under EEG DSA Guidance During Cardiac Electrophysiology Studies and Ablation","2026-12","Propofol",{"nctId":66,"briefTitle":67,"date":68,"intervention":69},"NCT07136545","A Phase I\u002FII Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)","2026-12-31","HCB101",{"nctId":71,"briefTitle":72,"date":68,"intervention":73},"NCT05805631","Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC","Pemetrexed",{"nctId":75,"briefTitle":76,"date":77,"intervention":78},"NCT03883022","Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery","2027-09-12","with U-VANCO",{"nctId":80,"briefTitle":81,"date":82,"intervention":83},"NCT07151703","Topical Versus Injection PRP for Olfactory Dysfunction","2027-12-31","platelet-rich plasma",[85,86,87,88,89,90],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[92,121,145,173,191,219,255,279,297,319,337,360,415,452,470,491,514,532,553,577,595,618,684,724,761,787,805,831,849,867,885,903,927,945,969,987,1005,1033,1060,1078,1104,1128,1146,1171,1196,1214,1238,1262,1289,1314,1332,1361,1379,1403,1421,1445,1463,1486,1513,1531,1549,1574,1592,1617,1641,1663,1688,1713,1735,1759,1786,1804,1829,1852,1880,1898,1922,1948,1973,1997,2021,2046,2070,2096,2121,2144,2168,2195,2266,2316,2350,2381,2407,2451,2483,2505,2531,2567,2602,2635,2663,2695,2713,2731,2749,2773,2796,2819,2837,2859,2883,2906,2924,2950,2968,2986,3012,3030,3048,3066,3094,3112,3130,3156,3174,3199,3217,3244,3268,3286,3304],{"intervention":93,"totalTrials":94,"cells":95},"Carvedilol alone",1,{"EARLY_PHASE1":96,"PHASE1":99,"PHASE2":101,"PHASE3":103,"PHASE4":105,"NA":119},{"trials":97,"activeCount":98},[],0,{"trials":100,"activeCount":98},[],{"trials":102,"activeCount":98},[],{"trials":104,"activeCount":98},[],{"trials":106,"activeCount":94,"soonestReadout":112},[107],{"nctId":108,"briefTitle":109,"status":110,"phases":111,"primaryCompletion":112,"completion":112,"start":113,"enrollment":114,"conditions":115,"interventions":118},"NCT06594783","Carvedilol Plus EVL or Not for the Primary Prevention of Esophageal Variceal Bleeding in Carvedilol Non-responders","RECRUITING",[89],"2030-10","2025-01-06",80,[116,117],"Cirrhosis","Esophageal Varices",[93],{"trials":120,"activeCount":98},[],{"intervention":122,"totalTrials":94,"cells":123},"Carvedilol",{"EARLY_PHASE1":124,"PHASE1":126,"PHASE2":128,"PHASE3":130,"PHASE4":132,"NA":143},{"trials":125,"activeCount":98},[],{"trials":127,"activeCount":98},[],{"trials":129,"activeCount":98},[],{"trials":131,"activeCount":98},[],{"trials":133,"activeCount":94,"soonestReadout":112},[134],{"nctId":135,"briefTitle":136,"status":110,"phases":137,"primaryCompletion":112,"completion":112,"start":138,"enrollment":139,"conditions":140,"interventions":142},"NCT06594744","Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC",[89],"2024-10-01",120,[141,117],"Hepatocellular Carcinoma (HCC)",[122],{"trials":144,"activeCount":98},[],{"intervention":146,"totalTrials":94,"cells":147},"Semaglutide 1.0 mg",{"EARLY_PHASE1":148,"PHASE1":150,"PHASE2":152,"PHASE3":154,"PHASE4":156,"NA":171},{"trials":149,"activeCount":98},[],{"trials":151,"activeCount":98},[],{"trials":153,"activeCount":98},[],{"trials":155,"activeCount":98},[],{"trials":157,"activeCount":94,"soonestReadout":163},[158],{"nctId":159,"briefTitle":160,"status":161,"phases":162,"primaryCompletion":163,"completion":163,"start":164,"enrollment":165,"conditions":166,"interventions":169},"NCT07073053","The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms","NOT_YET_RECRUITING",[89],"2028-07-31","2025-10-01",60,[167,18,168],"Glucagon-Like Peptide-1 Receptor Agonists","Coronary Arterial Disease (CAD)",[146,170],"Semaglutide 0.5 mg",{"trials":172,"activeCount":98},[],{"intervention":170,"totalTrials":94,"cells":174},{"EARLY_PHASE1":175,"PHASE1":177,"PHASE2":179,"PHASE3":181,"PHASE4":183,"NA":189},{"trials":176,"activeCount":98},[],{"trials":178,"activeCount":98},[],{"trials":180,"activeCount":98},[],{"trials":182,"activeCount":98},[],{"trials":184,"activeCount":94,"soonestReadout":163},[185],{"nctId":159,"briefTitle":160,"status":161,"phases":186,"primaryCompletion":163,"completion":163,"start":164,"enrollment":165,"conditions":187,"interventions":188},[89],[167,18,168],[146,170],{"trials":190,"activeCount":98},[],{"intervention":192,"totalTrials":94,"cells":193},"Ertapenem",{"EARLY_PHASE1":194,"PHASE1":196,"PHASE2":198,"PHASE3":200,"PHASE4":202,"NA":217},{"trials":195,"activeCount":98},[],{"trials":197,"activeCount":98},[],{"trials":199,"activeCount":98},[],{"trials":201,"activeCount":98},[],{"trials":203,"activeCount":94,"soonestReadout":208},[204],{"nctId":205,"briefTitle":206,"status":110,"phases":207,"primaryCompletion":208,"completion":208,"start":209,"enrollment":210,"conditions":211,"interventions":216},"NCT04140578","Antibiotic Prophylaxis in Patients Undergoing GVO",[89],"2030-12-31","2017-01-28",150,[212,213,214,215],"Gastric Varix","Sepsis","Liver Cirrhoses","Fever",[192],{"trials":218,"activeCount":98},[],{"intervention":220,"totalTrials":221,"cells":222},"Platelet-Rich Plasma",2,{"EARLY_PHASE1":223,"PHASE1":225,"PHASE2":239,"PHASE3":241,"PHASE4":251,"NA":253},{"trials":224,"activeCount":98},[],{"trials":226,"activeCount":98},[227],{"nctId":228,"briefTitle":229,"status":230,"phases":231,"primaryCompletion":232,"completion":232,"start":233,"enrollment":234,"conditions":235,"interventions":237},"NCT03548662","The Effect of Platelet Rich Plasma Injection Combined With Exercise Rehabilitation in Patients With Rotator Cuff Tear","COMPLETED",[86],"2018-02-06","2014-03-04",30,[236],"Rotator Cuff Tear",[220,238],"Hyaluronic Acid",{"trials":240,"activeCount":98},[],{"trials":242,"activeCount":94,"soonestReadout":82},[243],{"nctId":80,"briefTitle":81,"status":161,"phases":244,"primaryCompletion":82,"completion":245,"start":164,"enrollment":165,"conditions":246,"interventions":250},[88],"2028-12-31",[247,248,249],"Olfactory Dysfunction","Anosmia","Hyposmia",[83],{"trials":252,"activeCount":98},[],{"trials":254,"activeCount":98},[],{"intervention":44,"totalTrials":94,"cells":256},{"EARLY_PHASE1":257,"PHASE1":259,"PHASE2":261,"PHASE3":273,"PHASE4":275,"NA":277},{"trials":258,"activeCount":98},[],{"trials":260,"activeCount":98},[],{"trials":262,"activeCount":94,"soonestReadout":43},[263],{"nctId":41,"briefTitle":42,"status":110,"phases":264,"primaryCompletion":43,"completion":43,"start":265,"enrollment":114,"conditions":266,"interventions":271},[87],"2024-06-14",[267,268,269,270],"Sarcopenia","Frailty","Hyperglycemia","Hyperlipidemia",[44,272],"White job's tear",{"trials":274,"activeCount":98},[],{"trials":276,"activeCount":98},[],{"trials":278,"activeCount":98},[],{"intervention":272,"totalTrials":94,"cells":280},{"EARLY_PHASE1":281,"PHASE1":283,"PHASE2":285,"PHASE3":291,"PHASE4":293,"NA":295},{"trials":282,"activeCount":98},[],{"trials":284,"activeCount":98},[],{"trials":286,"activeCount":94,"soonestReadout":43},[287],{"nctId":41,"briefTitle":42,"status":110,"phases":288,"primaryCompletion":43,"completion":43,"start":265,"enrollment":114,"conditions":289,"interventions":290},[87],[267,268,269,270],[44,272],{"trials":292,"activeCount":98},[],{"trials":294,"activeCount":98},[],{"trials":296,"activeCount":98},[],{"intervention":69,"totalTrials":94,"cells":298},{"EARLY_PHASE1":299,"PHASE1":301,"PHASE2":303,"PHASE3":313,"PHASE4":315,"NA":317},{"trials":300,"activeCount":98},[],{"trials":302,"activeCount":98},[],{"trials":304,"activeCount":94,"soonestReadout":68},[305],{"nctId":66,"briefTitle":67,"status":110,"phases":306,"primaryCompletion":68,"completion":68,"start":307,"enrollment":308,"conditions":309,"interventions":311},[86,87],"2025-08-01",50,[310],"HNSCC",[69,312],"Pembrolizumab",{"trials":314,"activeCount":98},[],{"trials":316,"activeCount":98},[],{"trials":318,"activeCount":98},[],{"intervention":312,"totalTrials":94,"cells":320},{"EARLY_PHASE1":321,"PHASE1":323,"PHASE2":325,"PHASE3":331,"PHASE4":333,"NA":335},{"trials":322,"activeCount":98},[],{"trials":324,"activeCount":98},[],{"trials":326,"activeCount":94,"soonestReadout":68},[327],{"nctId":66,"briefTitle":67,"status":110,"phases":328,"primaryCompletion":68,"completion":68,"start":307,"enrollment":308,"conditions":329,"interventions":330},[86,87],[310],[69,312],{"trials":332,"activeCount":98},[],{"trials":334,"activeCount":98},[],{"trials":336,"activeCount":98},[],{"intervention":73,"totalTrials":94,"cells":338},{"EARLY_PHASE1":339,"PHASE1":341,"PHASE2":343,"PHASE3":354,"PHASE4":356,"NA":358},{"trials":340,"activeCount":98},[],{"trials":342,"activeCount":98},[],{"trials":344,"activeCount":94,"soonestReadout":68},[345],{"nctId":71,"briefTitle":72,"status":110,"phases":346,"primaryCompletion":68,"completion":82,"start":347,"enrollment":348,"conditions":349,"interventions":353},[87],"2024-08-01",23,[350,351,352],"Carcinoma, Non-Small-Cell Lung","Epidermal Growth Factor Receptor","Leptomeningeal Metastasis",[73],{"trials":355,"activeCount":98},[],{"trials":357,"activeCount":98},[],{"trials":359,"activeCount":98},[],{"intervention":64,"totalTrials":361,"cells":362},3,{"EARLY_PHASE1":363,"PHASE1":365,"PHASE2":367,"PHASE3":369,"PHASE4":371,"NA":373},{"trials":364,"activeCount":98},[],{"trials":366,"activeCount":98},[],{"trials":368,"activeCount":98},[],{"trials":370,"activeCount":98},[],{"trials":372,"activeCount":98},[],{"trials":374,"activeCount":94,"soonestReadout":63},[375,391,401],{"nctId":376,"briefTitle":377,"status":230,"phases":378,"primaryCompletion":379,"completion":380,"start":381,"enrollment":382,"conditions":383,"interventions":386},"NCT03813875","Modeling and Application of Triple Drug Response Surface Models",[],"2022-05-01","2022-05-25","2019-06-12",100,[384,385],"Pharmacodynamics","Drug Interactions",[387,388,64,389,390],"Fentanyl","alfentanil","sevoflurane","midazolam",{"nctId":61,"briefTitle":62,"status":392,"phases":393,"primaryCompletion":63,"completion":63,"start":394,"enrollment":395,"conditions":396,"interventions":400},"ENROLLING_BY_INVITATION",[90],"2024-09-20",200,[397,398,64,399],"Hemodynamic","Remimazolam","Cardiac Electrophysiology",[64,398],{"nctId":402,"briefTitle":403,"status":404,"phases":405,"primaryCompletion":406,"completion":407,"start":408,"enrollment":165,"conditions":409,"interventions":412},"NCT05525351","The Application and Validation of Triple Drug Response Surface Models on Density Spectral Array in Clinical Anesthesia","UNKNOWN",[],"2023-07","2024-07","2022-10",[30,410,411],"Drug Interaction","Anesthesia; Functional",[64,413,414],"Alfentanil","Dexmedetomidine",{"intervention":416,"totalTrials":221,"cells":417},"Atorvastatin",{"EARLY_PHASE1":418,"PHASE1":420,"PHASE2":422,"PHASE3":424,"PHASE4":426,"NA":439},{"trials":419,"activeCount":98},[],{"trials":421,"activeCount":98},[],{"trials":423,"activeCount":98},[],{"trials":425,"activeCount":98},[],{"trials":427,"activeCount":98},[428],{"nctId":429,"briefTitle":430,"status":404,"phases":431,"primaryCompletion":432,"completion":432,"start":433,"enrollment":434,"conditions":435,"interventions":437},"NCT04685642","Anti-inflmmation Treatment in Mood Disorder and Deep Learning Prediction Model",[89],"2023-07-31","2020-08-24",180,[436],"Mood Disorder",[438,416],"Aspirin",{"trials":440,"activeCount":94,"soonestReadout":445},[441],{"nctId":442,"briefTitle":443,"status":110,"phases":444,"primaryCompletion":445,"completion":446,"start":447,"enrollment":139,"conditions":448,"interventions":451},"NCT07400757","Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease",[90],"2029-12-31","2032-07-15","2026-02-24",[449,450],"Thyroid Eye Disease, TED","Graves Ophthalmopathy",[416],{"intervention":398,"totalTrials":94,"cells":453},{"EARLY_PHASE1":454,"PHASE1":456,"PHASE2":458,"PHASE3":460,"PHASE4":462,"NA":464},{"trials":455,"activeCount":98},[],{"trials":457,"activeCount":98},[],{"trials":459,"activeCount":98},[],{"trials":461,"activeCount":98},[],{"trials":463,"activeCount":98},[],{"trials":465,"activeCount":94,"soonestReadout":63},[466],{"nctId":61,"briefTitle":62,"status":392,"phases":467,"primaryCompletion":63,"completion":63,"start":394,"enrollment":395,"conditions":468,"interventions":469},[90],[397,398,64,399],[64,398],{"intervention":39,"totalTrials":94,"cells":471},{"EARLY_PHASE1":472,"PHASE1":474,"PHASE2":476,"PHASE3":478,"PHASE4":480,"NA":482},{"trials":473,"activeCount":98},[],{"trials":475,"activeCount":98},[],{"trials":477,"activeCount":98},[],{"trials":479,"activeCount":98},[],{"trials":481,"activeCount":98},[],{"trials":483,"activeCount":94,"soonestReadout":38},[484],{"nctId":36,"briefTitle":37,"status":161,"phases":485,"primaryCompletion":38,"completion":68,"start":486,"enrollment":487,"conditions":488,"interventions":490},[],"2021-09-01",36,[489],"Glycogen Storage Disease Type II",[39],{"intervention":54,"totalTrials":94,"cells":492},{"EARLY_PHASE1":493,"PHASE1":495,"PHASE2":497,"PHASE3":499,"PHASE4":501,"NA":503},{"trials":494,"activeCount":98},[],{"trials":496,"activeCount":98},[],{"trials":498,"activeCount":98},[],{"trials":500,"activeCount":98},[],{"trials":502,"activeCount":98},[],{"trials":504,"activeCount":94,"soonestReadout":53},[505],{"nctId":51,"briefTitle":52,"status":161,"phases":506,"primaryCompletion":53,"completion":507,"start":508,"enrollment":509,"conditions":510,"interventions":512},[90],"2026-04-13","2025-06-01",154,[511],"Breast Engorgement",[54,513],"Sham Comparator",{"intervention":513,"totalTrials":94,"cells":515},{"EARLY_PHASE1":516,"PHASE1":518,"PHASE2":520,"PHASE3":522,"PHASE4":524,"NA":526},{"trials":517,"activeCount":98},[],{"trials":519,"activeCount":98},[],{"trials":521,"activeCount":98},[],{"trials":523,"activeCount":98},[],{"trials":525,"activeCount":98},[],{"trials":527,"activeCount":94,"soonestReadout":53},[528],{"nctId":51,"briefTitle":52,"status":161,"phases":529,"primaryCompletion":53,"completion":507,"start":508,"enrollment":509,"conditions":530,"interventions":531},[90],[511],[54,513],{"intervention":59,"totalTrials":94,"cells":533},{"EARLY_PHASE1":534,"PHASE1":536,"PHASE2":538,"PHASE3":540,"PHASE4":542,"NA":544},{"trials":535,"activeCount":98},[],{"trials":537,"activeCount":98},[],{"trials":539,"activeCount":98},[],{"trials":541,"activeCount":98},[],{"trials":543,"activeCount":98},[],{"trials":545,"activeCount":94,"soonestReadout":58},[546],{"nctId":56,"briefTitle":57,"status":161,"phases":547,"primaryCompletion":58,"completion":548,"start":549,"enrollment":139,"conditions":550,"interventions":552},[90],"2025-12-31","2025-05-28",[551],"Insomnia",[59],{"intervention":78,"totalTrials":94,"cells":554},{"EARLY_PHASE1":555,"PHASE1":557,"PHASE2":559,"PHASE3":561,"PHASE4":563,"NA":565},{"trials":556,"activeCount":98},[],{"trials":558,"activeCount":98},[],{"trials":560,"activeCount":98},[],{"trials":562,"activeCount":98},[],{"trials":564,"activeCount":98},[],{"trials":566,"activeCount":94,"soonestReadout":77},[567],{"nctId":75,"briefTitle":76,"status":110,"phases":568,"primaryCompletion":77,"completion":82,"start":569,"enrollment":570,"conditions":571,"interventions":575},[90],"2018-09-03",400,[572,573,574],"Spinal Fusion","Spinal Stenosis","Spondylolisthesis",[78,576],"without U-VANCO",{"intervention":576,"totalTrials":94,"cells":578},{"EARLY_PHASE1":579,"PHASE1":581,"PHASE2":583,"PHASE3":585,"PHASE4":587,"NA":589},{"trials":580,"activeCount":98},[],{"trials":582,"activeCount":98},[],{"trials":584,"activeCount":98},[],{"trials":586,"activeCount":98},[],{"trials":588,"activeCount":98},[],{"trials":590,"activeCount":94,"soonestReadout":77},[591],{"nctId":75,"briefTitle":76,"status":110,"phases":592,"primaryCompletion":77,"completion":82,"start":569,"enrollment":570,"conditions":593,"interventions":594},[90],[572,573,574],[78,576],{"intervention":49,"totalTrials":94,"cells":596},{"EARLY_PHASE1":597,"PHASE1":599,"PHASE2":601,"PHASE3":603,"PHASE4":605,"NA":607},{"trials":598,"activeCount":98},[],{"trials":600,"activeCount":98},[],{"trials":602,"activeCount":98},[],{"trials":604,"activeCount":98},[],{"trials":606,"activeCount":98},[],{"trials":608,"activeCount":94,"soonestReadout":48},[609],{"nctId":46,"briefTitle":47,"status":110,"phases":610,"primaryCompletion":48,"completion":68,"start":611,"enrollment":612,"conditions":613,"interventions":617},[],"2025-01-16",220,[614,615,616],"Dry Eye Syndrome (DES)","Sjogren's Syndrome","Xerophthalmia",[49],{"intervention":619,"totalTrials":620,"cells":621},"propranolol",5,{"EARLY_PHASE1":622,"PHASE1":624,"PHASE2":626,"PHASE3":628,"PHASE4":630,"NA":682},{"trials":623,"activeCount":98},[],{"trials":625,"activeCount":98},[],{"trials":627,"activeCount":98},[],{"trials":629,"activeCount":98},[],{"trials":631,"activeCount":98},[632,643,654,664,672],{"nctId":633,"briefTitle":634,"status":404,"phases":635,"primaryCompletion":636,"completion":637,"start":638,"enrollment":639,"conditions":640,"interventions":642},"NCT04074473","Impact of Nonselective Beta-blocker on Acute Kidney Injury in Cirrhotic Patients With Esophageal Varices",[89],"2015-11-05","2020-07-30","2015-04-13",170,[641,116,117],"Acute Kidney Injury",[619],{"nctId":644,"briefTitle":645,"status":404,"phases":646,"primaryCompletion":647,"completion":648,"start":649,"enrollment":165,"conditions":650,"interventions":653},"NCT01298284","A Trial of EVL\\GVS Alone vs. EVL\\GVS Combined Propranolol",[89],"2010-06","2011-12","2009-10",[651,652],"Liver Cirrhosis","Hepatoma",[619],{"nctId":655,"briefTitle":656,"status":404,"phases":657,"primaryCompletion":658,"completion":548,"start":659,"enrollment":395,"conditions":660,"interventions":662},"NCT01970748","Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices",[89],"2023-12-25","2009-08",[661,15],"Bleeding Esophageal Varices",[663],"Propranolol",{"nctId":665,"briefTitle":666,"status":404,"phases":667,"primaryCompletion":548,"completion":548,"start":668,"enrollment":139,"conditions":669,"interventions":671},"NCT01298271","A Randomized Trial of GVS Alone vs. Propranolol",[89],"2010-04",[670,651],"Bleeding Gastric Varices",[619],{"nctId":673,"briefTitle":674,"status":404,"phases":675,"primaryCompletion":676,"completion":677,"start":678,"enrollment":382,"conditions":679,"interventions":681},"NCT01451658","A Trial of EVL\\GVS Alone vs. EVL\\GVS Combined Propranolol (S-HCC)",[89],"2020-07-31","2020-12-31","2009-12",[680,15],"Gastroesophageal Varices Hemorrhage",[619],{"trials":683,"activeCount":98},[],{"intervention":685,"totalTrials":221,"cells":686},"Rosuvastatin",{"EARLY_PHASE1":687,"PHASE1":689,"PHASE2":691,"PHASE3":693,"PHASE4":695,"NA":722},{"trials":688,"activeCount":98},[],{"trials":690,"activeCount":98},[],{"trials":692,"activeCount":98},[],{"trials":694,"activeCount":98},[],{"trials":696,"activeCount":98},[697,710],{"nctId":698,"briefTitle":699,"status":404,"phases":700,"primaryCompletion":701,"completion":702,"start":703,"enrollment":704,"conditions":705,"interventions":707},"NCT01816997","The Statins on Glucose Homeostasis in Subjects With Impaired Fasting Glucose",[89],"2017-12","2022-12","2012-01",160,[706],"Diabetes",[708,685,709],"Pravastatin","Control",{"nctId":711,"briefTitle":712,"status":230,"phases":713,"primaryCompletion":714,"completion":714,"start":715,"enrollment":716,"conditions":717,"interventions":720},"NCT00506961","Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia",[89],"2007-07","2006-06",90,[718,719],"Diabetes Mellitus","Dyslipidemia",[685,721],"Simvastatin",{"trials":723,"activeCount":98},[],{"intervention":725,"totalTrials":221,"cells":726},"Flunarizine",{"EARLY_PHASE1":727,"PHASE1":729,"PHASE2":731,"PHASE3":733,"PHASE4":735,"NA":759},{"trials":728,"activeCount":98},[],{"trials":730,"activeCount":98},[],{"trials":732,"activeCount":98},[],{"trials":734,"activeCount":98},[],{"trials":736,"activeCount":98},[737,749],{"nctId":738,"briefTitle":739,"status":230,"phases":740,"primaryCompletion":741,"completion":742,"start":743,"enrollment":744,"conditions":745,"interventions":747},"NCT02639598","Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis",[89],"2014-12","2015-03","2012-06",62,[746],"Chronic Migraine",[725,748],"Topiramate",{"nctId":750,"briefTitle":751,"status":404,"phases":752,"primaryCompletion":43,"completion":753,"start":754,"enrollment":755,"conditions":756,"interventions":758},"NCT04702971","Decoding Pain Sensitivity in Migraine With Multimodal Brainstem-based Neurosignature",[89],"2025-12","2021-02-26",600,[757],"Migraine",[725],{"trials":760,"activeCount":98},[],{"intervention":762,"totalTrials":94,"cells":763},"Metformin",{"EARLY_PHASE1":764,"PHASE1":766,"PHASE2":768,"PHASE3":770,"PHASE4":772,"NA":785},{"trials":765,"activeCount":98},[],{"trials":767,"activeCount":98},[],{"trials":769,"activeCount":98},[],{"trials":771,"activeCount":98},[],{"trials":773,"activeCount":98},[774],{"nctId":775,"briefTitle":776,"status":404,"phases":777,"primaryCompletion":778,"completion":779,"start":780,"enrollment":704,"conditions":781,"interventions":782},"NCT01717911","ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia",[89],"2013-12","2018-12","2010-09",[18],[783,762,784],"Insulin","Sitagliptin",{"trials":786,"activeCount":98},[],{"intervention":784,"totalTrials":94,"cells":788},{"EARLY_PHASE1":789,"PHASE1":791,"PHASE2":793,"PHASE3":795,"PHASE4":797,"NA":803},{"trials":790,"activeCount":98},[],{"trials":792,"activeCount":98},[],{"trials":794,"activeCount":98},[],{"trials":796,"activeCount":98},[],{"trials":798,"activeCount":98},[799],{"nctId":775,"briefTitle":776,"status":404,"phases":800,"primaryCompletion":778,"completion":779,"start":780,"enrollment":704,"conditions":801,"interventions":802},[89],[18],[783,762,784],{"trials":804,"activeCount":98},[],{"intervention":806,"totalTrials":94,"cells":807},"Entecavir prophylaxis",{"EARLY_PHASE1":808,"PHASE1":810,"PHASE2":812,"PHASE3":814,"PHASE4":816,"NA":829},{"trials":809,"activeCount":98},[],{"trials":811,"activeCount":98},[],{"trials":813,"activeCount":98},[],{"trials":815,"activeCount":98},[],{"trials":817,"activeCount":98},[818],{"nctId":819,"briefTitle":820,"status":230,"phases":821,"primaryCompletion":822,"completion":822,"start":823,"enrollment":114,"conditions":824,"interventions":827},"NCT00926757","Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B",[89],"2012-11","2009-04",[825,826],"Non Hodgkin's Lymphoma","Hepatitis B",[806,828],"Therapeutic entecavir",{"trials":830,"activeCount":98},[],{"intervention":828,"totalTrials":94,"cells":832},{"EARLY_PHASE1":833,"PHASE1":835,"PHASE2":837,"PHASE3":839,"PHASE4":841,"NA":847},{"trials":834,"activeCount":98},[],{"trials":836,"activeCount":98},[],{"trials":838,"activeCount":98},[],{"trials":840,"activeCount":98},[],{"trials":842,"activeCount":98},[843],{"nctId":819,"briefTitle":820,"status":230,"phases":844,"primaryCompletion":822,"completion":822,"start":823,"enrollment":114,"conditions":845,"interventions":846},[89],[825,826],[806,828],{"trials":848,"activeCount":98},[],{"intervention":708,"totalTrials":94,"cells":850},{"EARLY_PHASE1":851,"PHASE1":853,"PHASE2":855,"PHASE3":857,"PHASE4":859,"NA":865},{"trials":852,"activeCount":98},[],{"trials":854,"activeCount":98},[],{"trials":856,"activeCount":98},[],{"trials":858,"activeCount":98},[],{"trials":860,"activeCount":98},[861],{"nctId":698,"briefTitle":699,"status":404,"phases":862,"primaryCompletion":701,"completion":702,"start":703,"enrollment":704,"conditions":863,"interventions":864},[89],[706],[708,685,709],{"trials":866,"activeCount":98},[],{"intervention":709,"totalTrials":94,"cells":868},{"EARLY_PHASE1":869,"PHASE1":871,"PHASE2":873,"PHASE3":875,"PHASE4":877,"NA":883},{"trials":870,"activeCount":98},[],{"trials":872,"activeCount":98},[],{"trials":874,"activeCount":98},[],{"trials":876,"activeCount":98},[],{"trials":878,"activeCount":98},[879],{"nctId":698,"briefTitle":699,"status":404,"phases":880,"primaryCompletion":701,"completion":702,"start":703,"enrollment":704,"conditions":881,"interventions":882},[89],[706],[708,685,709],{"trials":884,"activeCount":98},[],{"intervention":721,"totalTrials":94,"cells":886},{"EARLY_PHASE1":887,"PHASE1":889,"PHASE2":891,"PHASE3":893,"PHASE4":895,"NA":901},{"trials":888,"activeCount":98},[],{"trials":890,"activeCount":98},[],{"trials":892,"activeCount":98},[],{"trials":894,"activeCount":98},[],{"trials":896,"activeCount":98},[897],{"nctId":711,"briefTitle":712,"status":230,"phases":898,"primaryCompletion":714,"completion":714,"start":715,"enrollment":716,"conditions":899,"interventions":900},[89],[718,719],[685,721],{"trials":902,"activeCount":98},[],{"intervention":904,"totalTrials":94,"cells":905},"Exenatide",{"EARLY_PHASE1":906,"PHASE1":908,"PHASE2":910,"PHASE3":912,"PHASE4":914,"NA":925},{"trials":907,"activeCount":98},[],{"trials":909,"activeCount":98},[],{"trials":911,"activeCount":98},[],{"trials":913,"activeCount":98},[],{"trials":915,"activeCount":98},[916],{"nctId":917,"briefTitle":918,"status":404,"phases":919,"primaryCompletion":741,"completion":920,"start":921,"enrollment":704,"conditions":922,"interventions":923},"NCT01270191","The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients",[89],"2015-12","2010-11",[18],[904,924],"Humulin-N",{"trials":926,"activeCount":98},[],{"intervention":924,"totalTrials":94,"cells":928},{"EARLY_PHASE1":929,"PHASE1":931,"PHASE2":933,"PHASE3":935,"PHASE4":937,"NA":943},{"trials":930,"activeCount":98},[],{"trials":932,"activeCount":98},[],{"trials":934,"activeCount":98},[],{"trials":936,"activeCount":98},[],{"trials":938,"activeCount":98},[939],{"nctId":917,"briefTitle":918,"status":404,"phases":940,"primaryCompletion":741,"completion":920,"start":921,"enrollment":704,"conditions":941,"interventions":942},[89],[18],[904,924],{"trials":944,"activeCount":98},[],{"intervention":946,"totalTrials":94,"cells":947},"flunarizine and\u002For pregabalin",{"EARLY_PHASE1":948,"PHASE1":950,"PHASE2":952,"PHASE3":954,"PHASE4":956,"NA":967},{"trials":949,"activeCount":98},[],{"trials":951,"activeCount":98},[],{"trials":953,"activeCount":98},[],{"trials":955,"activeCount":98},[],{"trials":957,"activeCount":98},[958],{"nctId":959,"briefTitle":960,"status":230,"phases":961,"primaryCompletion":962,"start":920,"enrollment":395,"conditions":963,"interventions":966},"NCT02747940","Neurologic Signatures of Chronic Pain Disorders",[89],"2019-12",[964,746,965],"Chronic Pain","Fibromyalgia",[946],{"trials":968,"activeCount":98},[],{"intervention":438,"totalTrials":94,"cells":970},{"EARLY_PHASE1":971,"PHASE1":973,"PHASE2":975,"PHASE3":977,"PHASE4":979,"NA":985},{"trials":972,"activeCount":98},[],{"trials":974,"activeCount":98},[],{"trials":976,"activeCount":98},[],{"trials":978,"activeCount":98},[],{"trials":980,"activeCount":98},[981],{"nctId":429,"briefTitle":430,"status":404,"phases":982,"primaryCompletion":432,"completion":432,"start":433,"enrollment":434,"conditions":983,"interventions":984},[89],[436],[438,416],{"trials":986,"activeCount":98},[],{"intervention":748,"totalTrials":94,"cells":988},{"EARLY_PHASE1":989,"PHASE1":991,"PHASE2":993,"PHASE3":995,"PHASE4":997,"NA":1003},{"trials":990,"activeCount":98},[],{"trials":992,"activeCount":98},[],{"trials":994,"activeCount":98},[],{"trials":996,"activeCount":98},[],{"trials":998,"activeCount":98},[999],{"nctId":738,"briefTitle":739,"status":230,"phases":1000,"primaryCompletion":741,"completion":742,"start":743,"enrollment":744,"conditions":1001,"interventions":1002},[89],[746],[725,748],{"trials":1004,"activeCount":98},[],{"intervention":1006,"totalTrials":94,"cells":1007},"Ketamine and Midazolam",{"EARLY_PHASE1":1008,"PHASE1":1010,"PHASE2":1012,"PHASE3":1014,"PHASE4":1016,"NA":1031},{"trials":1009,"activeCount":98},[],{"trials":1011,"activeCount":98},[],{"trials":1013,"activeCount":98},[],{"trials":1015,"activeCount":98},[],{"trials":1017,"activeCount":98},[1018],{"nctId":1019,"briefTitle":1020,"status":230,"phases":1021,"primaryCompletion":1022,"completion":1022,"start":1023,"enrollment":1024,"conditions":1025,"interventions":1028},"NCT05045378","Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression",[89],"2024-11-30","2022-03-15",12,[1026,1027],"Treatment-resistant Depression","Major Depressive Disorder",[1029,1006,1030],"Midazolam","Ketamine",{"trials":1032,"activeCount":98},[],{"intervention":1034,"totalTrials":94,"cells":1035},"losartan",{"EARLY_PHASE1":1036,"PHASE1":1038,"PHASE2":1040,"PHASE3":1042,"PHASE4":1044,"NA":1058},{"trials":1037,"activeCount":98},[],{"trials":1039,"activeCount":98},[],{"trials":1041,"activeCount":98},[],{"trials":1043,"activeCount":98},[],{"trials":1045,"activeCount":98},[1046],{"nctId":1047,"briefTitle":1048,"status":230,"phases":1049,"primaryCompletion":1050,"completion":1051,"start":1052,"enrollment":1053,"conditions":1054,"interventions":1056},"NCT00754429","The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)",[89],"2009-06","2009-07","2004-06",40,[1055],"Ischemic Stroke",[1034,1057],"amlodipine",{"trials":1059,"activeCount":98},[],{"intervention":1057,"totalTrials":94,"cells":1061},{"EARLY_PHASE1":1062,"PHASE1":1064,"PHASE2":1066,"PHASE3":1068,"PHASE4":1070,"NA":1076},{"trials":1063,"activeCount":98},[],{"trials":1065,"activeCount":98},[],{"trials":1067,"activeCount":98},[],{"trials":1069,"activeCount":98},[],{"trials":1071,"activeCount":98},[1072],{"nctId":1047,"briefTitle":1048,"status":230,"phases":1073,"primaryCompletion":1050,"completion":1051,"start":1052,"enrollment":1053,"conditions":1074,"interventions":1075},[89],[1055],[1034,1057],{"trials":1077,"activeCount":98},[],{"intervention":1079,"totalTrials":94,"cells":1080},"Tenofovir alafenamide",{"EARLY_PHASE1":1081,"PHASE1":1083,"PHASE2":1085,"PHASE3":1087,"PHASE4":1089,"NA":1102},{"trials":1082,"activeCount":98},[],{"trials":1084,"activeCount":98},[],{"trials":1086,"activeCount":98},[],{"trials":1088,"activeCount":98},[],{"trials":1090,"activeCount":98},[1091],{"nctId":1092,"briefTitle":1093,"status":404,"phases":1094,"primaryCompletion":1095,"completion":548,"start":1096,"enrollment":1097,"conditions":1098,"interventions":1101},"NCT05001672","The Efficacy of Prophylactic TAF for HBsAg-positive Patients Receiving bDMARDs",[89],"2025-06-30","2021-08-15",108,[1099,1100],"HBV","Inflammatory Arthritis",[1079],{"trials":1103,"activeCount":98},[],{"intervention":1105,"totalTrials":94,"cells":1106},"Tenofovir disoproxil fumarate",{"EARLY_PHASE1":1107,"PHASE1":1109,"PHASE2":1111,"PHASE3":1113,"PHASE4":1115,"NA":1126},{"trials":1108,"activeCount":98},[],{"trials":1110,"activeCount":98},[],{"trials":1112,"activeCount":98},[],{"trials":1114,"activeCount":98},[],{"trials":1116,"activeCount":98},[1117],{"nctId":1118,"briefTitle":1119,"status":404,"phases":1120,"primaryCompletion":962,"completion":962,"start":1121,"enrollment":704,"conditions":1122,"interventions":1124},"NCT01491295","Switch to Tenofovir Versus Continue Lamivudine\u002FAdefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients",[89],"2012-09",[1123],"Chronic Hepatitis B",[1105,1125],"Lamivudine plus adefovir",{"trials":1127,"activeCount":98},[],{"intervention":1125,"totalTrials":94,"cells":1129},{"EARLY_PHASE1":1130,"PHASE1":1132,"PHASE2":1134,"PHASE3":1136,"PHASE4":1138,"NA":1144},{"trials":1131,"activeCount":98},[],{"trials":1133,"activeCount":98},[],{"trials":1135,"activeCount":98},[],{"trials":1137,"activeCount":98},[],{"trials":1139,"activeCount":98},[1140],{"nctId":1118,"briefTitle":1119,"status":404,"phases":1141,"primaryCompletion":962,"completion":962,"start":1121,"enrollment":704,"conditions":1142,"interventions":1143},[89],[1123],[1105,1125],{"trials":1145,"activeCount":98},[],{"intervention":1147,"totalTrials":94,"cells":1148},"fluticasone\u002Fsalmeterol, tiotropium",{"EARLY_PHASE1":1149,"PHASE1":1151,"PHASE2":1153,"PHASE3":1155,"PHASE4":1157,"NA":1169},{"trials":1150,"activeCount":98},[],{"trials":1152,"activeCount":98},[],{"trials":1154,"activeCount":98},[],{"trials":1156,"activeCount":98},[],{"trials":1158,"activeCount":98},[1159],{"nctId":1160,"briefTitle":1161,"status":404,"phases":1162,"primaryCompletion":920,"completion":1163,"start":1164,"enrollment":1165,"conditions":1166,"interventions":1168},"NCT02546349","Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS\u002FLABA Versus LAMA",[89],"2016-01","2014-07",143,[1167],"COPD",[1147],{"trials":1170,"activeCount":98},[],{"intervention":1172,"totalTrials":94,"cells":1173},"Raltegravir",{"EARLY_PHASE1":1174,"PHASE1":1176,"PHASE2":1178,"PHASE3":1180,"PHASE4":1182,"NA":1194},{"trials":1175,"activeCount":98},[],{"trials":1177,"activeCount":98},[],{"trials":1179,"activeCount":98},[],{"trials":1181,"activeCount":98},[],{"trials":1183,"activeCount":98},[1184],{"nctId":1185,"briefTitle":1186,"status":230,"phases":1187,"primaryCompletion":920,"completion":701,"start":1188,"enrollment":1189,"conditions":1190,"interventions":1192},"NCT01989910","Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients",[89],"2013-09",107,[1191],"HIV-1 Infection",[1172,1193],"Efavirenz",{"trials":1195,"activeCount":98},[],{"intervention":1193,"totalTrials":94,"cells":1197},{"EARLY_PHASE1":1198,"PHASE1":1200,"PHASE2":1202,"PHASE3":1204,"PHASE4":1206,"NA":1212},{"trials":1199,"activeCount":98},[],{"trials":1201,"activeCount":98},[],{"trials":1203,"activeCount":98},[],{"trials":1205,"activeCount":98},[],{"trials":1207,"activeCount":98},[1208],{"nctId":1185,"briefTitle":1186,"status":230,"phases":1209,"primaryCompletion":920,"completion":701,"start":1188,"enrollment":1189,"conditions":1210,"interventions":1211},[89],[1191],[1172,1193],{"trials":1213,"activeCount":98},[],{"intervention":1215,"totalTrials":94,"cells":1216},"mirabegron",{"EARLY_PHASE1":1217,"PHASE1":1219,"PHASE2":1221,"PHASE3":1223,"PHASE4":1225,"NA":1236},{"trials":1218,"activeCount":98},[],{"trials":1220,"activeCount":98},[],{"trials":1222,"activeCount":98},[],{"trials":1224,"activeCount":98},[],{"trials":1226,"activeCount":98},[1227],{"nctId":1228,"briefTitle":1229,"status":404,"phases":1230,"primaryCompletion":1231,"completion":1231,"start":1232,"enrollment":434,"conditions":1233,"interventions":1235},"NCT05188742","Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial",[89],"2023-09","2021-11-10",[1234],"Overactive Bladder Syndrome",[1215],{"trials":1237,"activeCount":98},[],{"intervention":1239,"totalTrials":94,"cells":1240},"Ginkgo Biloba Extract",{"EARLY_PHASE1":1241,"PHASE1":1243,"PHASE2":1245,"PHASE3":1247,"PHASE4":1249,"NA":1260},{"trials":1242,"activeCount":98},[],{"trials":1244,"activeCount":98},[],{"trials":1246,"activeCount":98},[],{"trials":1248,"activeCount":98},[],{"trials":1250,"activeCount":98},[1251],{"nctId":1252,"briefTitle":1253,"status":404,"phases":1254,"primaryCompletion":921,"completion":1255,"start":649,"enrollment":165,"conditions":1256,"interventions":1259},"NCT01038050","Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease",[89],"2010-12",[1257,1258],"Type 2 Diabetes Mellitus","Coronary Artery Disease",[1239],{"trials":1261,"activeCount":98},[],{"intervention":1263,"totalTrials":94,"cells":1264},"CERA",{"EARLY_PHASE1":1265,"PHASE1":1267,"PHASE2":1269,"PHASE3":1271,"PHASE4":1273,"NA":1287},{"trials":1266,"activeCount":98},[],{"trials":1268,"activeCount":98},[],{"trials":1270,"activeCount":98},[],{"trials":1272,"activeCount":98},[],{"trials":1274,"activeCount":98},[1275],{"nctId":1276,"briefTitle":1277,"status":230,"phases":1278,"primaryCompletion":1279,"completion":1279,"start":1280,"enrollment":1281,"conditions":1282,"interventions":1286},"NCT02232113","Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients",[89],"2013-01","2012-02",67,[1283,1284,1285],"Anemia","Inflammation","Malnutrition",[1263],{"trials":1288,"activeCount":98},[],{"intervention":1290,"totalTrials":94,"cells":1291},"Ledipasvir 90mg\u002FSofosbuvir 400 mg",{"EARLY_PHASE1":1292,"PHASE1":1294,"PHASE2":1296,"PHASE3":1298,"PHASE4":1300,"NA":1312},{"trials":1293,"activeCount":98},[],{"trials":1295,"activeCount":98},[],{"trials":1297,"activeCount":98},[],{"trials":1299,"activeCount":98},[],{"trials":1301,"activeCount":98},[1302],{"nctId":1303,"briefTitle":1304,"status":1305,"phases":1306,"primaryCompletion":1307,"completion":702,"start":1308,"enrollment":98,"conditions":1309,"interventions":1310},"NCT02959359","DAA in the Risk of Recurrence After Curative Treatment of HCC","WITHDRAWN",[89],"2022-06","2016-11",[15],[1290,1311],"Ribavirin",{"trials":1313,"activeCount":98},[],{"intervention":1311,"totalTrials":94,"cells":1315},{"EARLY_PHASE1":1316,"PHASE1":1318,"PHASE2":1320,"PHASE3":1322,"PHASE4":1324,"NA":1330},{"trials":1317,"activeCount":98},[],{"trials":1319,"activeCount":98},[],{"trials":1321,"activeCount":98},[],{"trials":1323,"activeCount":98},[],{"trials":1325,"activeCount":98},[1326],{"nctId":1303,"briefTitle":1304,"status":1305,"phases":1327,"primaryCompletion":1307,"completion":702,"start":1308,"enrollment":98,"conditions":1328,"interventions":1329},[89],[15],[1290,1311],{"trials":1331,"activeCount":98},[],{"intervention":1333,"totalTrials":94,"cells":1334},"Opioid-Sparing Protocol",{"EARLY_PHASE1":1335,"PHASE1":1337,"PHASE2":1339,"PHASE3":1341,"PHASE4":1343,"NA":1359},{"trials":1336,"activeCount":98},[],{"trials":1338,"activeCount":98},[],{"trials":1340,"activeCount":98},[],{"trials":1342,"activeCount":98},[],{"trials":1344,"activeCount":98},[1345],{"nctId":1346,"briefTitle":1347,"status":404,"phases":1348,"primaryCompletion":1349,"completion":1350,"start":1351,"enrollment":1352,"conditions":1353,"interventions":1357},"NCT04314505","Opioid-Sparing Protocol Comparing With Opioid-based Protocol After Bilateral Total Knee Arthroplasty",[89],"2020-06-20","2020-08-20","2020-03-20",56,[1354,1355,1356],"Knee Replacement","Postoperative Pain","Opioid Use",[1333,1358],"Opioid-Based Patient Controlled Analgesia",{"trials":1360,"activeCount":98},[],{"intervention":1358,"totalTrials":94,"cells":1362},{"EARLY_PHASE1":1363,"PHASE1":1365,"PHASE2":1367,"PHASE3":1369,"PHASE4":1371,"NA":1377},{"trials":1364,"activeCount":98},[],{"trials":1366,"activeCount":98},[],{"trials":1368,"activeCount":98},[],{"trials":1370,"activeCount":98},[],{"trials":1372,"activeCount":98},[1373],{"nctId":1346,"briefTitle":1347,"status":404,"phases":1374,"primaryCompletion":1349,"completion":1350,"start":1351,"enrollment":1352,"conditions":1375,"interventions":1376},[89],[1354,1355,1356],[1333,1358],{"trials":1378,"activeCount":98},[],{"intervention":1380,"totalTrials":94,"cells":1381},"Actos",{"EARLY_PHASE1":1382,"PHASE1":1384,"PHASE2":1386,"PHASE3":1388,"PHASE4":1390,"NA":1401},{"trials":1383,"activeCount":98},[],{"trials":1385,"activeCount":98},[],{"trials":1387,"activeCount":98},[],{"trials":1389,"activeCount":98},[],{"trials":1391,"activeCount":98},[1392],{"nctId":1393,"briefTitle":1394,"status":404,"phases":1395,"primaryCompletion":1396,"completion":920,"start":1397,"enrollment":395,"conditions":1398,"interventions":1399},"NCT01175486","Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy",[89],"2012-12","2010-07",[706],[1380,1400],"Acarbose",{"trials":1402,"activeCount":98},[],{"intervention":1400,"totalTrials":94,"cells":1404},{"EARLY_PHASE1":1405,"PHASE1":1407,"PHASE2":1409,"PHASE3":1411,"PHASE4":1413,"NA":1419},{"trials":1406,"activeCount":98},[],{"trials":1408,"activeCount":98},[],{"trials":1410,"activeCount":98},[],{"trials":1412,"activeCount":98},[],{"trials":1414,"activeCount":98},[1415],{"nctId":1393,"briefTitle":1394,"status":404,"phases":1416,"primaryCompletion":1396,"completion":920,"start":1397,"enrollment":395,"conditions":1417,"interventions":1418},[89],[706],[1380,1400],{"trials":1420,"activeCount":98},[],{"intervention":1422,"totalTrials":94,"cells":1423},"Ticagrelor",{"EARLY_PHASE1":1424,"PHASE1":1426,"PHASE2":1428,"PHASE3":1430,"PHASE4":1432,"NA":1443},{"trials":1425,"activeCount":98},[],{"trials":1427,"activeCount":98},[],{"trials":1429,"activeCount":98},[],{"trials":1431,"activeCount":98},[],{"trials":1433,"activeCount":98},[1434],{"nctId":1435,"briefTitle":1436,"status":404,"phases":1437,"primaryCompletion":1438,"completion":1438,"start":1163,"enrollment":395,"conditions":1439,"interventions":1441},"NCT02792712","Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI",[89],"2018-01",[1440],"Acute Coronary Syndrome",[1422,1442],"Clopidogrel",{"trials":1444,"activeCount":98},[],{"intervention":1442,"totalTrials":94,"cells":1446},{"EARLY_PHASE1":1447,"PHASE1":1449,"PHASE2":1451,"PHASE3":1453,"PHASE4":1455,"NA":1461},{"trials":1448,"activeCount":98},[],{"trials":1450,"activeCount":98},[],{"trials":1452,"activeCount":98},[],{"trials":1454,"activeCount":98},[],{"trials":1456,"activeCount":98},[1457],{"nctId":1435,"briefTitle":1436,"status":404,"phases":1458,"primaryCompletion":1438,"completion":1438,"start":1163,"enrollment":395,"conditions":1459,"interventions":1460},[89],[1440],[1422,1442],{"trials":1462,"activeCount":98},[],{"intervention":1464,"totalTrials":94,"cells":1465},"Ursodeoxycholic Acid",{"EARLY_PHASE1":1466,"PHASE1":1468,"PHASE2":1470,"PHASE3":1472,"PHASE4":1474,"NA":1484},{"trials":1467,"activeCount":98},[],{"trials":1469,"activeCount":98},[],{"trials":1471,"activeCount":98},[],{"trials":1473,"activeCount":98},[],{"trials":1475,"activeCount":98},[1476],{"nctId":1477,"briefTitle":1478,"status":404,"phases":1479,"primaryCompletion":668,"completion":1397,"start":1480,"enrollment":434,"conditions":1481,"interventions":1483},"NCT01141322","Cholestatic Drug-induced Liver Injury",[89],"2007-08",[1482],"Hepatitis, Toxic",[1464],{"trials":1485,"activeCount":98},[],{"intervention":1487,"totalTrials":94,"cells":1488},"amisulpride",{"EARLY_PHASE1":1489,"PHASE1":1491,"PHASE2":1493,"PHASE3":1495,"PHASE4":1497,"NA":1511},{"trials":1490,"activeCount":98},[],{"trials":1492,"activeCount":98},[],{"trials":1494,"activeCount":98},[],{"trials":1496,"activeCount":98},[],{"trials":1498,"activeCount":98},[1499],{"nctId":1500,"briefTitle":1501,"status":230,"phases":1502,"primaryCompletion":1503,"completion":1503,"start":1504,"enrollment":114,"conditions":1505,"interventions":1508},"NCT00926965","Tardive Dyskinesia and Cognitive Function",[89],"2007-12","2003-01",[1506,1507],"Tardive Dyskinesia","Neurocognitive Function",[1487,1509,1510],"Olanzapine","Conventional antipsychotics",{"trials":1512,"activeCount":98},[],{"intervention":1509,"totalTrials":94,"cells":1514},{"EARLY_PHASE1":1515,"PHASE1":1517,"PHASE2":1519,"PHASE3":1521,"PHASE4":1523,"NA":1529},{"trials":1516,"activeCount":98},[],{"trials":1518,"activeCount":98},[],{"trials":1520,"activeCount":98},[],{"trials":1522,"activeCount":98},[],{"trials":1524,"activeCount":98},[1525],{"nctId":1500,"briefTitle":1501,"status":230,"phases":1526,"primaryCompletion":1503,"completion":1503,"start":1504,"enrollment":114,"conditions":1527,"interventions":1528},[89],[1506,1507],[1487,1509,1510],{"trials":1530,"activeCount":98},[],{"intervention":1510,"totalTrials":94,"cells":1532},{"EARLY_PHASE1":1533,"PHASE1":1535,"PHASE2":1537,"PHASE3":1539,"PHASE4":1541,"NA":1547},{"trials":1534,"activeCount":98},[],{"trials":1536,"activeCount":98},[],{"trials":1538,"activeCount":98},[],{"trials":1540,"activeCount":98},[],{"trials":1542,"activeCount":98},[1543],{"nctId":1500,"briefTitle":1501,"status":230,"phases":1544,"primaryCompletion":1503,"completion":1503,"start":1504,"enrollment":114,"conditions":1545,"interventions":1546},[89],[1506,1507],[1487,1509,1510],{"trials":1548,"activeCount":98},[],{"intervention":1550,"totalTrials":94,"cells":1551},"fluticasone\u002F salmeterol 125\u002F25 mcg\u002Fpuff",{"EARLY_PHASE1":1552,"PHASE1":1554,"PHASE2":1556,"PHASE3":1558,"PHASE4":1560,"NA":1572},{"trials":1553,"activeCount":98},[],{"trials":1555,"activeCount":98},[],{"trials":1557,"activeCount":98},[],{"trials":1559,"activeCount":98},[],{"trials":1561,"activeCount":98},[1562],{"nctId":1563,"briefTitle":1564,"status":404,"phases":1565,"primaryCompletion":921,"completion":1566,"start":678,"enrollment":1567,"conditions":1568,"interventions":1570},"NCT01131806","Comparing Treatment Efficacy With HD\u002FMD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients",[89],"2011-04",124,[1569],"Chronic Obstructive Pulmonary Disease",[1550,1571],"fluticasone\u002F salmeterol 250\u002F25 mcg\u002Fpuff",{"trials":1573,"activeCount":98},[],{"intervention":1571,"totalTrials":94,"cells":1575},{"EARLY_PHASE1":1576,"PHASE1":1578,"PHASE2":1580,"PHASE3":1582,"PHASE4":1584,"NA":1590},{"trials":1577,"activeCount":98},[],{"trials":1579,"activeCount":98},[],{"trials":1581,"activeCount":98},[],{"trials":1583,"activeCount":98},[],{"trials":1585,"activeCount":98},[1586],{"nctId":1563,"briefTitle":1564,"status":404,"phases":1587,"primaryCompletion":921,"completion":1566,"start":678,"enrollment":1567,"conditions":1588,"interventions":1589},[89],[1569],[1550,1571],{"trials":1591,"activeCount":98},[],{"intervention":1593,"totalTrials":94,"cells":1594},"Vemlidy®",{"EARLY_PHASE1":1595,"PHASE1":1597,"PHASE2":1599,"PHASE3":1601,"PHASE4":1603,"NA":1615},{"trials":1596,"activeCount":98},[],{"trials":1598,"activeCount":98},[],{"trials":1600,"activeCount":98},[],{"trials":1602,"activeCount":98},[],{"trials":1604,"activeCount":98},[1605],{"nctId":1606,"briefTitle":1607,"status":404,"phases":1608,"primaryCompletion":38,"completion":1609,"start":1610,"enrollment":1611,"conditions":1612,"interventions":1614},"NCT04290936","Tenofovir Alafenamide(TAF) Reduces the Risk of Hepatocellular Carcinoma(HCC) Recurrence",[89],"2024-12-31","2020-10-16",402,[1613],"HCC Patients After Curative Treatment With Low HBV Viral Load",[1593],{"trials":1616,"activeCount":98},[],{"intervention":1618,"totalTrials":94,"cells":1619},"Docetaxel and pemetrexed",{"EARLY_PHASE1":1620,"PHASE1":1622,"PHASE2":1624,"PHASE3":1626,"PHASE4":1628,"NA":1639},{"trials":1621,"activeCount":98},[],{"trials":1623,"activeCount":98},[],{"trials":1625,"activeCount":98},[],{"trials":1627,"activeCount":98},[],{"trials":1629,"activeCount":98},[1630],{"nctId":1631,"briefTitle":1632,"status":230,"phases":1633,"primaryCompletion":1634,"completion":1634,"start":1635,"enrollment":8,"conditions":1636,"interventions":1638},"NCT01442909","Pemetrexed Followed by Docetaxel or in Reverse Sequence",[89],"2009-09","2008-03",[1637],"Non-small-cell Lung Cancer",[1618],{"trials":1640,"activeCount":98},[],{"intervention":1642,"totalTrials":94,"cells":1643},"Cefazolin",{"EARLY_PHASE1":1644,"PHASE1":1646,"PHASE2":1648,"PHASE3":1650,"PHASE4":1652,"NA":1661},{"trials":1645,"activeCount":98},[],{"trials":1647,"activeCount":98},[],{"trials":1649,"activeCount":98},[],{"trials":1651,"activeCount":98},[],{"trials":1653,"activeCount":98},[1654],{"nctId":1655,"briefTitle":1656,"status":404,"phases":1657,"primaryCompletion":701,"completion":701,"start":1658,"enrollment":755,"conditions":1659,"interventions":1660},"NCT02534961","Prophylactic Antibiotics Before RFA for HCC",[89],"2015-01",[15],[1642],{"trials":1662,"activeCount":98},[],{"intervention":1664,"totalTrials":94,"cells":1665},"0.5mg Baraclude",{"EARLY_PHASE1":1666,"PHASE1":1668,"PHASE2":1670,"PHASE3":1672,"PHASE4":1674,"NA":1686},{"trials":1667,"activeCount":98},[],{"trials":1669,"activeCount":98},[],{"trials":1671,"activeCount":98},[],{"trials":1673,"activeCount":98},[],{"trials":1675,"activeCount":98},[1676],{"nctId":1677,"briefTitle":1678,"status":404,"phases":1679,"primaryCompletion":1680,"completion":1681,"start":1682,"enrollment":1683,"conditions":1684,"interventions":1685},"NCT03308890","The Effect of Entecavir Consolidation on Post-TDF Treatment Durability",[89],"2019-07-01","2022-04-30","2017-11-01",156,[1123],[1664,1664],{"trials":1687,"activeCount":98},[],{"intervention":1689,"totalTrials":94,"cells":1690},"BH4",{"EARLY_PHASE1":1691,"PHASE1":1693,"PHASE2":1695,"PHASE3":1697,"PHASE4":1699,"NA":1711},{"trials":1692,"activeCount":98},[],{"trials":1694,"activeCount":98},[],{"trials":1696,"activeCount":98},[],{"trials":1698,"activeCount":98},[],{"trials":1700,"activeCount":98},[1701],{"nctId":1702,"briefTitle":1703,"status":404,"phases":1704,"primaryCompletion":1705,"completion":1307,"start":1706,"enrollment":1053,"conditions":1707,"interventions":1710},"NCT04227080","BH4 Responsiveness in PAH Deficiency PKU Patients",[89],"2021-12","2020-06",[1708,1709],"Pku Phenylketonuria","PAH Deficiency",[1689],{"trials":1712,"activeCount":98},[],{"intervention":1714,"totalTrials":94,"cells":1715},"Concurrent chemoradiotherapy",{"EARLY_PHASE1":1716,"PHASE1":1718,"PHASE2":1720,"PHASE3":1722,"PHASE4":1724,"NA":1733},{"trials":1717,"activeCount":98},[],{"trials":1719,"activeCount":98},[],{"trials":1721,"activeCount":98},[],{"trials":1723,"activeCount":98},[],{"trials":1725,"activeCount":98},[1726],{"nctId":1727,"briefTitle":1728,"status":230,"phases":1729,"primaryCompletion":823,"completion":649,"start":1730,"enrollment":24,"conditions":1731,"interventions":1732},"NCT00686322","Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)",[89],"2008-04",[1637],[1714],{"trials":1734,"activeCount":98},[],{"intervention":1736,"totalTrials":94,"cells":1737},"Nadolol",{"EARLY_PHASE1":1738,"PHASE1":1740,"PHASE2":1742,"PHASE3":1744,"PHASE4":1746,"NA":1757},{"trials":1739,"activeCount":98},[],{"trials":1741,"activeCount":98},[],{"trials":1743,"activeCount":98},[],{"trials":1745,"activeCount":98},[],{"trials":1747,"activeCount":98},[1748],{"nctId":1749,"briefTitle":1750,"status":404,"phases":1751,"completion":1397,"start":1752,"enrollment":139,"conditions":1753,"interventions":1756},"NCT00567216","Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding",[89],"2007-04",[1754,1755],"Liver Cirrhosis and Hepatoma.","Gastric Variceal Bleeding",[1736],{"trials":1758,"activeCount":98},[],{"intervention":1760,"totalTrials":94,"cells":1761},"Pemetrexed 500mg\u002Fm2 iv",{"EARLY_PHASE1":1762,"PHASE1":1764,"PHASE2":1766,"PHASE3":1768,"PHASE4":1782,"NA":1784},{"trials":1763,"activeCount":98},[],{"trials":1765,"activeCount":98},[],{"trials":1767,"activeCount":98},[],{"trials":1769,"activeCount":98},[1770],{"nctId":1771,"briefTitle":1772,"status":404,"phases":1773,"primaryCompletion":1774,"completion":1775,"start":1776,"enrollment":1777,"conditions":1778,"interventions":1780},"NCT01579630","Genius Study Study to Compare Efficacy and Safety of Gefitinib\u002F Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed\u002F Platinum as First-line Therapy",[87,88],"2013-06","2014-06","2011-03",52,[1779],"NSCLC",[1760,1781],"Pemetrexed 500mg\u002Fm2 iv and Gefitinib 250 mg",{"trials":1783,"activeCount":98},[],{"trials":1785,"activeCount":98},[],{"intervention":1781,"totalTrials":94,"cells":1787},{"EARLY_PHASE1":1788,"PHASE1":1790,"PHASE2":1792,"PHASE3":1794,"PHASE4":1800,"NA":1802},{"trials":1789,"activeCount":98},[],{"trials":1791,"activeCount":98},[],{"trials":1793,"activeCount":98},[],{"trials":1795,"activeCount":98},[1796],{"nctId":1771,"briefTitle":1772,"status":404,"phases":1797,"primaryCompletion":1774,"completion":1775,"start":1776,"enrollment":1777,"conditions":1798,"interventions":1799},[87,88],[1779],[1760,1781],{"trials":1801,"activeCount":98},[],{"trials":1803,"activeCount":98},[],{"intervention":1805,"totalTrials":94,"cells":1806},"Xiao-Xian-Gui-Fu-Tang",{"EARLY_PHASE1":1807,"PHASE1":1809,"PHASE2":1811,"PHASE3":1813,"PHASE4":1825,"NA":1827},{"trials":1808,"activeCount":98},[],{"trials":1810,"activeCount":98},[],{"trials":1812,"activeCount":98},[],{"trials":1814,"activeCount":98},[1815],{"nctId":1816,"briefTitle":1817,"status":230,"phases":1818,"primaryCompletion":1819,"completion":1819,"start":1820,"enrollment":1821,"conditions":1822,"interventions":1824},"NCT04686955","The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal Medicine",[88],"2022-12-31","2021-01-25",19,[1823],"Atopic Dermatitis",[1805],{"trials":1826,"activeCount":98},[],{"trials":1828,"activeCount":98},[],{"intervention":1830,"totalTrials":94,"cells":1831},"GnRH agonist",{"EARLY_PHASE1":1832,"PHASE1":1834,"PHASE2":1836,"PHASE3":1838,"PHASE4":1848,"NA":1850},{"trials":1833,"activeCount":98},[],{"trials":1835,"activeCount":98},[],{"trials":1837,"activeCount":98},[],{"trials":1839,"activeCount":98},[1840],{"nctId":1841,"briefTitle":1842,"status":404,"phases":1843,"primaryCompletion":1844,"completion":780,"start":1635,"enrollment":114,"conditions":1845,"interventions":1847},"NCT01125488","Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery",[88],"2009-03",[1846],"Endometriosis",[1830],{"trials":1849,"activeCount":98},[],{"trials":1851,"activeCount":98},[],{"intervention":1853,"totalTrials":94,"cells":1854},"Proton-pump inhibitor",{"EARLY_PHASE1":1855,"PHASE1":1857,"PHASE2":1859,"PHASE3":1861,"PHASE4":1876,"NA":1878},{"trials":1856,"activeCount":98},[],{"trials":1858,"activeCount":98},[],{"trials":1860,"activeCount":98},[],{"trials":1862,"activeCount":98},[1863],{"nctId":1864,"briefTitle":1865,"status":1866,"phases":1867,"primaryCompletion":1868,"completion":1869,"start":1870,"enrollment":1871,"conditions":1872,"interventions":1874},"NCT04140591","Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis","TERMINATED",[87,88],"2019-10-31","2019-12-31","2016-12-26",10,[651,1873],"Peptic Ulcer",[1853,1875],"Propranolol+Proton-pump inhibitor",{"trials":1877,"activeCount":98},[],{"trials":1879,"activeCount":98},[],{"intervention":1875,"totalTrials":94,"cells":1881},{"EARLY_PHASE1":1882,"PHASE1":1884,"PHASE2":1886,"PHASE3":1888,"PHASE4":1894,"NA":1896},{"trials":1883,"activeCount":98},[],{"trials":1885,"activeCount":98},[],{"trials":1887,"activeCount":98},[],{"trials":1889,"activeCount":98},[1890],{"nctId":1864,"briefTitle":1865,"status":1866,"phases":1891,"primaryCompletion":1868,"completion":1869,"start":1870,"enrollment":1871,"conditions":1892,"interventions":1893},[87,88],[651,1873],[1853,1875],{"trials":1895,"activeCount":98},[],{"trials":1897,"activeCount":98},[],{"intervention":1899,"totalTrials":94,"cells":1900},"L-menthol",{"EARLY_PHASE1":1901,"PHASE1":1903,"PHASE2":1905,"PHASE3":1907,"PHASE4":1918,"NA":1920},{"trials":1902,"activeCount":98},[],{"trials":1904,"activeCount":98},[],{"trials":1906,"activeCount":98},[],{"trials":1908,"activeCount":98},[1909],{"nctId":1910,"briefTitle":1911,"status":404,"phases":1912,"primaryCompletion":1913,"completion":1913,"start":1914,"enrollment":165,"conditions":1915,"interventions":1917},"NCT04593836","Antiperistaltic Effect and Safety of L-menthol in the Elderly With Contraindication to Buscopan",[88],"2020-12","2012-03",[1916],"Upper Gastrointestinal Endoscopy",[1899],{"trials":1919,"activeCount":98},[],{"trials":1921,"activeCount":98},[],{"intervention":1923,"totalTrials":94,"cells":1924},"Dehydroepiandrosterone",{"EARLY_PHASE1":1925,"PHASE1":1927,"PHASE2":1929,"PHASE3":1931,"PHASE4":1944,"NA":1946},{"trials":1926,"activeCount":98},[],{"trials":1928,"activeCount":98},[],{"trials":1930,"activeCount":98},[],{"trials":1932,"activeCount":98},[1933],{"nctId":1934,"briefTitle":1935,"status":230,"phases":1936,"primaryCompletion":1937,"completion":1937,"start":1279,"enrollment":1053,"conditions":1938,"interventions":1943},"NCT02150330","Effects of Dehydroepiandrosterone Supplementation on Cumulus Cells Gene Expression Under Controlled Ovarian Hyper-stimulation in Patients With Diminished Ovarian Reserve",[88],"2013-10",[1923,1939,1940,1941,1942],"DHEAS","Gene Expression of Cumulus Cells.","Ovarian Hyper-stimulation Protocol.","Artificial Reproduction Technology.",[1923],{"trials":1945,"activeCount":98},[],{"trials":1947,"activeCount":98},[],{"intervention":1949,"totalTrials":94,"cells":1950},"Aflibercept Injection [Eylea]",{"EARLY_PHASE1":1951,"PHASE1":1953,"PHASE2":1955,"PHASE3":1957,"PHASE4":1969,"NA":1971},{"trials":1952,"activeCount":98},[],{"trials":1954,"activeCount":98},[],{"trials":1956,"activeCount":98},[],{"trials":1958,"activeCount":98},[1959],{"nctId":1960,"briefTitle":1961,"status":230,"phases":1962,"primaryCompletion":1963,"completion":1963,"start":1964,"enrollment":1965,"conditions":1966,"interventions":1968},"NCT04288232","Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan",[88],"2017-11-16","2015-08-31",45,[1967],"Center-involved Diabetic Macular Edema",[1949],{"trials":1970,"activeCount":98},[],{"trials":1972,"activeCount":98},[],{"intervention":1974,"totalTrials":94,"cells":1975},"VGH-AD1",{"EARLY_PHASE1":1976,"PHASE1":1978,"PHASE2":1980,"PHASE3":1991,"PHASE4":1993,"NA":1995},{"trials":1977,"activeCount":98},[],{"trials":1979,"activeCount":98},[],{"trials":1981,"activeCount":98},[1982],{"nctId":1983,"briefTitle":1984,"status":404,"phases":1985,"primaryCompletion":677,"completion":677,"start":1986,"enrollment":1987,"conditions":1988,"interventions":1990},"NCT04249869","The Efficacy of Traditional Chinese Herbal Medicine for Alzheimer's Disease",[86,87],"2020-02-01",28,[1989],"Alzheimer Disease",[1974],{"trials":1992,"activeCount":98},[],{"trials":1994,"activeCount":98},[],{"trials":1996,"activeCount":98},[],{"intervention":1998,"totalTrials":94,"cells":1999},"Capecitabine",{"EARLY_PHASE1":2000,"PHASE1":2002,"PHASE2":2004,"PHASE3":2015,"PHASE4":2017,"NA":2019},{"trials":2001,"activeCount":98},[],{"trials":2003,"activeCount":98},[],{"trials":2005,"activeCount":98},[2006],{"nctId":2007,"briefTitle":2008,"status":404,"phases":2009,"primaryCompletion":1279,"start":2010,"enrollment":2011,"conditions":2012,"interventions":2014},"NCT01331928","Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer",[87],"2011-01",51,[2013],"Gastric Cancer",[1998],{"trials":2016,"activeCount":98},[],{"trials":2018,"activeCount":98},[],{"trials":2020,"activeCount":98},[],{"intervention":2022,"totalTrials":94,"cells":2023},"YQ1",{"EARLY_PHASE1":2024,"PHASE1":2026,"PHASE2":2028,"PHASE3":2040,"PHASE4":2042,"NA":2044},{"trials":2025,"activeCount":98},[],{"trials":2027,"activeCount":98},[],{"trials":2029,"activeCount":98},[2030],{"nctId":2031,"briefTitle":2032,"status":404,"phases":2033,"primaryCompletion":2034,"completion":2035,"start":2036,"enrollment":1352,"conditions":2037,"interventions":2039},"NCT02967497","Clinical Study of YQ1 Plus Cisplatin-based Chemotherapy in Advanced NSCLC EGFR Wild Type",[87],"2017-09","2018-09","2016-10",[2038],"Epithelial Growth Factor Receptor Negative Non-small Cell Lung Cancer",[2022],{"trials":2041,"activeCount":98},[],{"trials":2043,"activeCount":98},[],{"trials":2045,"activeCount":98},[],{"intervention":2047,"totalTrials":94,"cells":2048},"UFUR and Iressa",{"EARLY_PHASE1":2049,"PHASE1":2051,"PHASE2":2053,"PHASE3":2064,"PHASE4":2066,"NA":2068},{"trials":2050,"activeCount":98},[],{"trials":2052,"activeCount":98},[],{"trials":2054,"activeCount":98},[2055],{"nctId":2056,"briefTitle":2057,"status":230,"phases":2058,"primaryCompletion":678,"completion":678,"start":2059,"enrollment":2060,"conditions":2061,"interventions":2063},"NCT01037998","UFUR (Tegafur\u002FUracil) Plus Iressa in Non-small-cell Lung Cancer",[87],"2005-11",115,[2062],"Non-Small-Cell Lung Cancer",[2047],{"trials":2065,"activeCount":98},[],{"trials":2067,"activeCount":98},[],{"trials":2069,"activeCount":98},[],{"intervention":2071,"totalTrials":94,"cells":2072},"Chondrochymal®",{"EARLY_PHASE1":2073,"PHASE1":2075,"PHASE2":2077,"PHASE3":2090,"PHASE4":2092,"NA":2094},{"trials":2074,"activeCount":98},[],{"trials":2076,"activeCount":98},[],{"trials":2078,"activeCount":98},[2079],{"nctId":2080,"briefTitle":2081,"status":230,"phases":2082,"primaryCompletion":2083,"completion":2084,"start":2085,"enrollment":2086,"conditions":2087,"interventions":2089},"NCT03589287","Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis",[86,87],"2019-05-03","2020-04-30","2018-05-02",18,[2088],"Knee Osteoarthritis",[2071],{"trials":2091,"activeCount":98},[],{"trials":2093,"activeCount":98},[],{"trials":2095,"activeCount":98},[],{"intervention":2097,"totalTrials":94,"cells":2098},"Erlotinib",{"EARLY_PHASE1":2099,"PHASE1":2101,"PHASE2":2103,"PHASE3":2115,"PHASE4":2117,"NA":2119},{"trials":2100,"activeCount":98},[],{"trials":2102,"activeCount":98},[],{"trials":2104,"activeCount":98},[2105],{"nctId":2106,"briefTitle":2107,"status":404,"phases":2108,"primaryCompletion":2109,"completion":2109,"start":2110,"enrollment":2111,"conditions":2112,"interventions":2114},"NCT01608841","The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib",[87],"2015-10","2005-07",88,[2113],"Metastatic Pancreatic Cancer",[2097],{"trials":2116,"activeCount":98},[],{"trials":2118,"activeCount":98},[],{"trials":2120,"activeCount":98},[],{"intervention":2122,"totalTrials":94,"cells":2123},"doxorubicin",{"EARLY_PHASE1":2124,"PHASE1":2126,"PHASE2":2128,"PHASE3":2138,"PHASE4":2140,"NA":2142},{"trials":2125,"activeCount":98},[],{"trials":2127,"activeCount":98},[],{"trials":2129,"activeCount":98},[2130],{"nctId":2131,"briefTitle":2132,"status":404,"phases":2133,"primaryCompletion":2134,"start":2135,"enrollment":487,"conditions":2136,"interventions":2137},"NCT00990860","Study in Asia of the Combination of TACE With Sorafenib in HCC Patients",[87],"2011-02","2009-02",[15],[2122],{"trials":2139,"activeCount":98},[],{"trials":2141,"activeCount":98},[],{"trials":2143,"activeCount":98},[],{"intervention":2145,"totalTrials":94,"cells":2146},"VGH-BPH1",{"EARLY_PHASE1":2147,"PHASE1":2149,"PHASE2":2151,"PHASE3":2162,"PHASE4":2164,"NA":2166},{"trials":2148,"activeCount":98},[],{"trials":2150,"activeCount":98},[],{"trials":2152,"activeCount":98},[2153],{"nctId":2154,"briefTitle":2155,"status":230,"phases":2156,"primaryCompletion":2157,"completion":2157,"start":2158,"enrollment":348,"conditions":2159,"interventions":2161},"NCT03829904","The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia",[86,87],"2020-01-02","2019-03-06",[2160],"Benign Prostatic Hyperplasia",[2145],{"trials":2163,"activeCount":98},[],{"trials":2165,"activeCount":98},[],{"trials":2167,"activeCount":98},[],{"intervention":2169,"totalTrials":94,"cells":2170},"Induction chemotherapy",{"EARLY_PHASE1":2171,"PHASE1":2173,"PHASE2":2175,"PHASE3":2189,"PHASE4":2191,"NA":2193},{"trials":2172,"activeCount":98},[],{"trials":2174,"activeCount":98},[],{"trials":2176,"activeCount":98},[2177],{"nctId":2178,"briefTitle":2179,"status":1866,"phases":2180,"primaryCompletion":2181,"completion":2182,"start":2183,"enrollment":348,"conditions":2184,"interventions":2188},"NCT03161548","A Study of Tongue Conservation Surgery for Oral Tongue Cancer",[87],"2016-01-27","2017-01-04","2011-07-18",[2185,2186,2187],"Tongue Cancer","Chemotherapy Effect","Surgery",[2169],{"trials":2190,"activeCount":98},[],{"trials":2192,"activeCount":98},[],{"trials":2194,"activeCount":98},[],{"intervention":2196,"totalTrials":24,"cells":2197},"Triamcinolone Acetonide",{"EARLY_PHASE1":2198,"PHASE1":2200,"PHASE2":2202,"PHASE3":2204,"PHASE4":2206,"NA":2208},{"trials":2199,"activeCount":98},[],{"trials":2201,"activeCount":98},[],{"trials":2203,"activeCount":98},[],{"trials":2205,"activeCount":98},[],{"trials":2207,"activeCount":98},[],{"trials":2209,"activeCount":98},[2210,2220,2229,2238,2248,2258],{"nctId":2211,"briefTitle":2212,"status":404,"phases":2213,"primaryCompletion":2214,"completion":2214,"start":2215,"enrollment":114,"conditions":2216,"interventions":2217},"NCT04364425","Steroid Injection for Adhesive Capsulitis",[90],"2021-09","2020-05-04",[23],[2196,2218,2219],"lidocaine hydrochloride","Normal saline",{"nctId":2221,"briefTitle":2222,"status":230,"phases":2223,"primaryCompletion":2224,"completion":1775,"start":2225,"enrollment":1777,"conditions":2226,"interventions":2228},"NCT02708693","Efficacy of Combined Ultrasound Guided Steroid Injection and Splinting in Patients With Carpal Tunnel Syndrome",[90],"2014-04","2013-04",[2227],"Carpal Tunnel Syndrome",[2196,2218],{"nctId":2230,"briefTitle":2231,"status":230,"phases":2232,"primaryCompletion":2233,"completion":2234,"start":2235,"enrollment":1352,"conditions":2236,"interventions":2237},"NCT03072290","Corticosteroid Injection in Carpal Tunnel Syndrome",[90],"2018-11-28","2018-12-20","2017-02-18",[2227],[2196,2218],{"nctId":2239,"briefTitle":2240,"status":404,"phases":2241,"primaryCompletion":2242,"completion":2242,"start":2243,"enrollment":2244,"conditions":2245,"interventions":2246},"NCT05861570","Is Combined Steroid and Sodium Hyaluronate Hydrodilatation More Effective Than Isolated Steroid Hydrodilatation in Treating Patients With Adhesive Capsulitis",[90],"2024-04-06","2023-05-18",84,[23],[2247,2218,2196],"normal saline",{"nctId":2249,"briefTitle":2250,"status":230,"phases":2251,"primaryCompletion":2252,"completion":2253,"start":822,"enrollment":487,"conditions":2254,"interventions":2256},"NCT01950793","A Comparison Between Sonoguided Injection Corticosteroid and Hyaluronic Acid Injection in Treatment of Trigger Finger",[90],"2014-05","2014-08",[2255],"Trigger Finger",[2257,238],"triamcinolone acetonide",{"nctId":2259,"briefTitle":2260,"status":404,"phases":2261,"primaryCompletion":2262,"completion":2262,"start":2263,"enrollment":165,"conditions":2264,"interventions":2265},"NCT04346030","Comparison of Ultrasound-guided Corticosteroid Injection Versus Corticosteroid Injection and Hydrodissection for Carpal Tunnel Syndrome",[90],"2021-07","2020-04-17",[2227],[2196,2218,2247],{"intervention":238,"totalTrials":620,"cells":2267},{"EARLY_PHASE1":2268,"PHASE1":2270,"PHASE2":2276,"PHASE3":2278,"PHASE4":2280,"NA":2282},{"trials":2269,"activeCount":98},[],{"trials":2271,"activeCount":98},[2272],{"nctId":228,"briefTitle":229,"status":230,"phases":2273,"primaryCompletion":232,"completion":232,"start":233,"enrollment":234,"conditions":2274,"interventions":2275},[86],[236],[220,238],{"trials":2277,"activeCount":98},[],{"trials":2279,"activeCount":98},[],{"trials":2281,"activeCount":98},[],{"trials":2283,"activeCount":98},[2284,2295,2304,2308],{"nctId":2285,"briefTitle":2286,"status":404,"phases":2287,"primaryCompletion":2288,"completion":2288,"start":2288,"enrollment":382,"conditions":2289,"interventions":2292},"NCT03167333","The Role of Synovitis in Osteoarthritis",[90],"2020-03-01",[2290,2291],"Synovitis of Knee","Osteoarthritis, Knee",[2293,2294],"platelet rich plasma","Hyaluronic acid",{"nctId":2296,"briefTitle":2297,"status":404,"phases":2298,"primaryCompletion":2299,"completion":2299,"start":2300,"enrollment":395,"conditions":2301,"interventions":2303},"NCT03677895","What Factors Are Associated With Prognosis of Rotator Cuff Disorder After Subacromial Hyaluronic Acid Injection",[90],"2019-03-01","2018-10-08",[2302],"Rotator Cuff Impingement Syndrome",[238],{"nctId":2249,"briefTitle":2250,"status":230,"phases":2305,"primaryCompletion":2252,"completion":2253,"start":822,"enrollment":487,"conditions":2306,"interventions":2307},[90],[2255],[2257,238],{"nctId":2309,"briefTitle":2310,"status":230,"phases":2311,"primaryCompletion":1913,"completion":1913,"start":2312,"enrollment":744,"conditions":2313,"interventions":2314},"NCT02708706","The Efficacy of Ultrasound-guided Hydrodilatation With Hyaluronic Acid for Patients With Adhesive Capsulitis",[90],"2016-03",[23],[2315],"hyaluronic acid",{"intervention":2218,"totalTrials":620,"cells":2317},{"EARLY_PHASE1":2318,"PHASE1":2320,"PHASE2":2322,"PHASE3":2324,"PHASE4":2326,"NA":2328},{"trials":2319,"activeCount":98},[],{"trials":2321,"activeCount":98},[],{"trials":2323,"activeCount":98},[],{"trials":2325,"activeCount":98},[],{"trials":2327,"activeCount":98},[],{"trials":2329,"activeCount":98},[2330,2334,2338,2342,2346],{"nctId":2211,"briefTitle":2212,"status":404,"phases":2331,"primaryCompletion":2214,"completion":2214,"start":2215,"enrollment":114,"conditions":2332,"interventions":2333},[90],[23],[2196,2218,2219],{"nctId":2221,"briefTitle":2222,"status":230,"phases":2335,"primaryCompletion":2224,"completion":1775,"start":2225,"enrollment":1777,"conditions":2336,"interventions":2337},[90],[2227],[2196,2218],{"nctId":2230,"briefTitle":2231,"status":230,"phases":2339,"primaryCompletion":2233,"completion":2234,"start":2235,"enrollment":1352,"conditions":2340,"interventions":2341},[90],[2227],[2196,2218],{"nctId":2239,"briefTitle":2240,"status":404,"phases":2343,"primaryCompletion":2242,"completion":2242,"start":2243,"enrollment":2244,"conditions":2344,"interventions":2345},[90],[23],[2247,2218,2196],{"nctId":2259,"briefTitle":2260,"status":404,"phases":2347,"primaryCompletion":2262,"completion":2262,"start":2263,"enrollment":165,"conditions":2348,"interventions":2349},[90],[2227],[2196,2218,2247],{"intervention":1029,"totalTrials":361,"cells":2351},{"EARLY_PHASE1":2352,"PHASE1":2354,"PHASE2":2356,"PHASE3":2358,"PHASE4":2360,"NA":2366},{"trials":2353,"activeCount":98},[],{"trials":2355,"activeCount":98},[],{"trials":2357,"activeCount":98},[],{"trials":2359,"activeCount":98},[],{"trials":2361,"activeCount":98},[2362],{"nctId":1019,"briefTitle":1020,"status":230,"phases":2363,"primaryCompletion":1022,"completion":1022,"start":1023,"enrollment":1024,"conditions":2364,"interventions":2365},[89],[1026,1027],[1029,1006,1030],{"trials":2367,"activeCount":98},[2368,2372],{"nctId":376,"briefTitle":377,"status":230,"phases":2369,"primaryCompletion":379,"completion":380,"start":381,"enrollment":382,"conditions":2370,"interventions":2371},[],[384,385],[387,388,64,389,390],{"nctId":2373,"briefTitle":2374,"status":404,"phases":2375,"primaryCompletion":2376,"completion":2376,"start":2377,"enrollment":2378,"conditions":2379,"interventions":2380},"NCT03666390","Using a Low Dose of Ketamine vs. Active Placebo in Treating Severe Depression and Suicide",[90],"2021-12-31","2018-09-10",48,[1027],[1030,1029],{"intervention":2247,"totalTrials":361,"cells":2382},{"EARLY_PHASE1":2383,"PHASE1":2385,"PHASE2":2387,"PHASE3":2389,"PHASE4":2391,"NA":2393},{"trials":2384,"activeCount":98},[],{"trials":2386,"activeCount":98},[],{"trials":2388,"activeCount":98},[],{"trials":2390,"activeCount":98},[],{"trials":2392,"activeCount":98},[],{"trials":2394,"activeCount":98},[2395,2399,2403],{"nctId":2211,"briefTitle":2212,"status":404,"phases":2396,"primaryCompletion":2214,"completion":2214,"start":2215,"enrollment":114,"conditions":2397,"interventions":2398},[90],[23],[2196,2218,2219],{"nctId":2239,"briefTitle":2240,"status":404,"phases":2400,"primaryCompletion":2242,"completion":2242,"start":2243,"enrollment":2244,"conditions":2401,"interventions":2402},[90],[23],[2247,2218,2196],{"nctId":2259,"briefTitle":2260,"status":404,"phases":2404,"primaryCompletion":2262,"completion":2262,"start":2263,"enrollment":165,"conditions":2405,"interventions":2406},[90],[2227],[2196,2218,2247],{"intervention":2408,"totalTrials":361,"cells":2409},"steroid",{"EARLY_PHASE1":2410,"PHASE1":2412,"PHASE2":2414,"PHASE3":2416,"PHASE4":2418,"NA":2420},{"trials":2411,"activeCount":98},[],{"trials":2413,"activeCount":98},[],{"trials":2415,"activeCount":98},[],{"trials":2417,"activeCount":98},[],{"trials":2419,"activeCount":98},[],{"trials":2421,"activeCount":98},[2422,2430,2443],{"nctId":2423,"briefTitle":2424,"status":404,"phases":2425,"primaryCompletion":2299,"completion":2299,"start":2426,"enrollment":382,"conditions":2427,"interventions":2428},"NCT03622853","What Factors Area Associated With Prognosis After Steroid Hydrodilatation for Adhesive Capsulitis",[90],"2018-01-01",[23],[2429],"Steroid",{"nctId":2431,"briefTitle":2432,"status":404,"phases":2433,"primaryCompletion":2434,"completion":2435,"start":2436,"enrollment":2437,"conditions":2438,"interventions":2439},"NCT05818111","Comparison of Different Volume of Steroid Hydrodilatation in Treating Patients With Adhesive Capsulitis",[90],"2024-01-31","2024-02-01","2023-01-31",86,[23],[2408,2440,2441,2442],"Xylocaine 2 % Injectable Solution","Normal saline 2cc","normal saline 12cc",{"nctId":2444,"briefTitle":2445,"status":404,"phases":2446,"primaryCompletion":2447,"completion":2447,"start":2225,"enrollment":2448,"conditions":2449,"interventions":2450},"NCT03132051","Sonographic Evaluation of Patients With Carpal Tunnel Syndrome Following Steroid Injection",[90],"2018-02",54,[2227],[2408],{"intervention":1030,"totalTrials":361,"cells":2452},{"EARLY_PHASE1":2453,"PHASE1":2455,"PHASE2":2457,"PHASE3":2459,"PHASE4":2461,"NA":2467},{"trials":2454,"activeCount":98},[],{"trials":2456,"activeCount":98},[],{"trials":2458,"activeCount":98},[],{"trials":2460,"activeCount":98},[],{"trials":2462,"activeCount":98},[2463],{"nctId":1019,"briefTitle":1020,"status":230,"phases":2464,"primaryCompletion":1022,"completion":1022,"start":1023,"enrollment":1024,"conditions":2465,"interventions":2466},[89],[1026,1027],[1029,1006,1030],{"trials":2468,"activeCount":98},[2469,2479],{"nctId":2470,"briefTitle":2471,"status":404,"phases":2472,"primaryCompletion":1819,"completion":1819,"start":2473,"enrollment":716,"conditions":2474,"interventions":2478},"NCT05256264","Machine-learning Algorithm to Differentiate Intraoperative Ketamine Dosing Based on Electroencephalographic Density Spectrum Array Analysis",[],"2022-03-01",[2475,2476,1030,2477],"Electroencephalographic Density Spectrum Array Analysis","Density Spectrum Array","Multimodal General Anesthesia",[1030],{"nctId":2373,"briefTitle":2374,"status":404,"phases":2480,"primaryCompletion":2376,"completion":2376,"start":2377,"enrollment":2378,"conditions":2481,"interventions":2482},[90],[1027],[1030,1029],{"intervention":388,"totalTrials":221,"cells":2484},{"EARLY_PHASE1":2485,"PHASE1":2487,"PHASE2":2489,"PHASE3":2491,"PHASE4":2493,"NA":2495},{"trials":2486,"activeCount":98},[],{"trials":2488,"activeCount":98},[],{"trials":2490,"activeCount":98},[],{"trials":2492,"activeCount":98},[],{"trials":2494,"activeCount":98},[],{"trials":2496,"activeCount":98},[2497,2501],{"nctId":376,"briefTitle":377,"status":230,"phases":2498,"primaryCompletion":379,"completion":380,"start":381,"enrollment":382,"conditions":2499,"interventions":2500},[],[384,385],[387,388,64,389,390],{"nctId":402,"briefTitle":403,"status":404,"phases":2502,"primaryCompletion":406,"completion":407,"start":408,"enrollment":165,"conditions":2503,"interventions":2504},[],[30,410,411],[64,413,414],{"intervention":783,"totalTrials":221,"cells":2506},{"EARLY_PHASE1":2507,"PHASE1":2509,"PHASE2":2511,"PHASE3":2513,"PHASE4":2515,"NA":2521},{"trials":2508,"activeCount":98},[],{"trials":2510,"activeCount":98},[],{"trials":2512,"activeCount":98},[],{"trials":2514,"activeCount":98},[],{"trials":2516,"activeCount":98},[2517],{"nctId":775,"briefTitle":776,"status":404,"phases":2518,"primaryCompletion":778,"completion":779,"start":780,"enrollment":704,"conditions":2519,"interventions":2520},[89],[18],[783,762,784],{"trials":2522,"activeCount":98},[2523],{"nctId":2524,"briefTitle":2525,"status":230,"phases":2526,"primaryCompletion":1480,"completion":648,"start":2527,"enrollment":165,"conditions":2528,"interventions":2529},"NCT00506194","Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control",[90],"2005-10",[18],[783,2530],"OAD",{"intervention":2532,"totalTrials":221,"cells":2533},"Tranexamic Acid Powder",{"EARLY_PHASE1":2534,"PHASE1":2536,"PHASE2":2538,"PHASE3":2540,"PHASE4":2542,"NA":2544},{"trials":2535,"activeCount":98},[],{"trials":2537,"activeCount":98},[],{"trials":2539,"activeCount":98},[],{"trials":2541,"activeCount":98},[],{"trials":2543,"activeCount":98},[],{"trials":2545,"activeCount":98},[2546,2558],{"nctId":2547,"briefTitle":2548,"status":230,"phases":2549,"primaryCompletion":2550,"completion":2551,"start":2552,"enrollment":210,"conditions":2553,"interventions":2557},"NCT06280456","Tranexamic Acid Injection With Different Drainage Clamping Time After Anterior Cruciate Ligament Reconstruction",[90],"2023-01-05","2023-02-05","2022-09-05",[2554,2555,2556],"Anterior Cruciate Ligament Reconstruction","Tranexamic Acid","Hemarthrosis, Knee",[2532],{"nctId":2559,"briefTitle":2560,"status":230,"phases":2561,"primaryCompletion":2562,"completion":2562,"start":2563,"enrollment":2564,"conditions":2565,"interventions":2566},"NCT03580018","Intraarticular Injection of Tranexamic Acid Reduced Postoperative Hemarthrosis in Arthroscopic Anterior Cruciate Ligament Reconstruction",[90],"2018-05-31","2017-06-01",320,[2554],[2532],{"intervention":2568,"totalTrials":221,"cells":2569},"lansoprazole",{"EARLY_PHASE1":2570,"PHASE1":2572,"PHASE2":2574,"PHASE3":2576,"PHASE4":2578,"NA":2580},{"trials":2571,"activeCount":98},[],{"trials":2573,"activeCount":98},[],{"trials":2575,"activeCount":98},[],{"trials":2577,"activeCount":98},[],{"trials":2579,"activeCount":98},[],{"trials":2581,"activeCount":98},[2582,2592],{"nctId":2583,"briefTitle":2584,"status":404,"phases":2585,"primaryCompletion":2586,"completion":779,"start":2587,"enrollment":139,"conditions":2588,"interventions":2590},"NCT03418337","Comparison of the Efficiency of Two Different PPI Formula in Atypical GERD",[90],"2018-07","2017-08-01",[2589],"Compare the Response Rate of Atypical GERD After PPI Therapy",[2591,2568],"dexilansoprazole",{"nctId":2593,"briefTitle":2594,"status":404,"phases":2595,"primaryCompletion":1255,"completion":1255,"start":2596,"enrollment":2597,"conditions":2598,"interventions":2600},"NCT00854776","Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor",[90],"2009-01",300,[1873,2599],"Ulcer Complications",[2568,2601],"aluminum hydroxide 334 mg and Mg hydroxide 166 mg",{"intervention":2603,"totalTrials":221,"cells":2604},"Entecavir",{"EARLY_PHASE1":2605,"PHASE1":2607,"PHASE2":2609,"PHASE3":2611,"PHASE4":2613,"NA":2626},{"trials":2606,"activeCount":98},[],{"trials":2608,"activeCount":98},[],{"trials":2610,"activeCount":98},[],{"trials":2612,"activeCount":98},[],{"trials":2614,"activeCount":98},[2615],{"nctId":2616,"briefTitle":2617,"status":404,"phases":2618,"primaryCompletion":2619,"completion":1869,"start":2620,"enrollment":2060,"conditions":2621,"interventions":2625},"NCT01907230","Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients",[89],"2018-12-31","2013-09-10",[2622,2623,2624],"Rheumatoid Arthritis","Hepatitis B Reactivation","Exposure to Hepatitis B Virus",[2603],{"trials":2627,"activeCount":98},[2628],{"nctId":2629,"briefTitle":2630,"status":404,"phases":2631,"start":2010,"enrollment":2632,"conditions":2633,"interventions":2634},"NCT01270178","Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy",[],420,[1123,15],[2603],{"intervention":2636,"totalTrials":221,"cells":2637},"Aliskiren",{"EARLY_PHASE1":2638,"PHASE1":2640,"PHASE2":2642,"PHASE3":2644,"PHASE4":2646,"NA":2656},{"trials":2639,"activeCount":98},[],{"trials":2641,"activeCount":98},[],{"trials":2643,"activeCount":98},[],{"trials":2645,"activeCount":98},[],{"trials":2647,"activeCount":98},[2648],{"nctId":2649,"briefTitle":2650,"status":404,"phases":2651,"primaryCompletion":2652,"start":1397,"enrollment":139,"conditions":2653,"interventions":2655},"NCT01156207","Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure",[89],"2013-07",[2654],"Heart Failure",[2636],{"trials":2657,"activeCount":98},[2658],{"nctId":2659,"briefTitle":2650,"status":404,"phases":2660,"primaryCompletion":2652,"completion":2652,"start":1397,"enrollment":139,"conditions":2661,"interventions":2662},"NCT01298258",[90],[2654],[2636],{"intervention":2664,"totalTrials":221,"cells":2665},"OSA",{"EARLY_PHASE1":2666,"PHASE1":2668,"PHASE2":2670,"PHASE3":2672,"PHASE4":2674,"NA":2676},{"trials":2667,"activeCount":98},[],{"trials":2669,"activeCount":98},[],{"trials":2671,"activeCount":98},[],{"trials":2673,"activeCount":98},[],{"trials":2675,"activeCount":98},[],{"trials":2677,"activeCount":98},[2678,2685],{"nctId":2679,"briefTitle":2680,"status":404,"phases":2681,"primaryCompletion":920,"completion":920,"start":1658,"enrollment":114,"conditions":2682,"interventions":2684},"NCT02342028","The Number and Function of Regular T Cell in Patients With Obstructive Sleep Apnea",[],[2683],"Sleep Apnea Syndromes",[2664],{"nctId":2686,"briefTitle":2687,"status":404,"phases":2688,"primaryCompletion":2689,"completion":2689,"start":2690,"enrollment":2691,"conditions":2692,"interventions":2694},"NCT03654456","Impact of Sleep Apnea on Sepsis Mortality",[],"2019-05-27","2018-05-28",280,[2683,213,2693],"Mortality",[2664],{"intervention":387,"totalTrials":94,"cells":2696},{"EARLY_PHASE1":2697,"PHASE1":2699,"PHASE2":2701,"PHASE3":2703,"PHASE4":2705,"NA":2707},{"trials":2698,"activeCount":98},[],{"trials":2700,"activeCount":98},[],{"trials":2702,"activeCount":98},[],{"trials":2704,"activeCount":98},[],{"trials":2706,"activeCount":98},[],{"trials":2708,"activeCount":98},[2709],{"nctId":376,"briefTitle":377,"status":230,"phases":2710,"primaryCompletion":379,"completion":380,"start":381,"enrollment":382,"conditions":2711,"interventions":2712},[],[384,385],[387,388,64,389,390],{"intervention":389,"totalTrials":94,"cells":2714},{"EARLY_PHASE1":2715,"PHASE1":2717,"PHASE2":2719,"PHASE3":2721,"PHASE4":2723,"NA":2725},{"trials":2716,"activeCount":98},[],{"trials":2718,"activeCount":98},[],{"trials":2720,"activeCount":98},[],{"trials":2722,"activeCount":98},[],{"trials":2724,"activeCount":98},[],{"trials":2726,"activeCount":98},[2727],{"nctId":376,"briefTitle":377,"status":230,"phases":2728,"primaryCompletion":379,"completion":380,"start":381,"enrollment":382,"conditions":2729,"interventions":2730},[],[384,385],[387,388,64,389,390],{"intervention":2293,"totalTrials":94,"cells":2732},{"EARLY_PHASE1":2733,"PHASE1":2735,"PHASE2":2737,"PHASE3":2739,"PHASE4":2741,"NA":2743},{"trials":2734,"activeCount":98},[],{"trials":2736,"activeCount":98},[],{"trials":2738,"activeCount":98},[],{"trials":2740,"activeCount":98},[],{"trials":2742,"activeCount":98},[],{"trials":2744,"activeCount":98},[2745],{"nctId":2285,"briefTitle":2286,"status":404,"phases":2746,"primaryCompletion":2288,"completion":2288,"start":2288,"enrollment":382,"conditions":2747,"interventions":2748},[90],[2290,2291],[2293,2294],{"intervention":2750,"totalTrials":94,"cells":2751},"Herbal medicine",{"EARLY_PHASE1":2752,"PHASE1":2754,"PHASE2":2756,"PHASE3":2758,"PHASE4":2760,"NA":2762},{"trials":2753,"activeCount":98},[],{"trials":2755,"activeCount":98},[],{"trials":2757,"activeCount":98},[],{"trials":2759,"activeCount":98},[],{"trials":2761,"activeCount":98},[],{"trials":2763,"activeCount":98},[2764],{"nctId":2765,"briefTitle":2766,"status":404,"phases":2767,"primaryCompletion":1869,"completion":677,"start":2768,"enrollment":2769,"conditions":2770,"interventions":2772},"NCT03838952","The Efficacy of Traditional Chinese Herbal Medicine for Dementia",[90],"2019-02-11",20,[2771,1989],"Dementia",[2750],{"intervention":2774,"totalTrials":94,"cells":2775},"rabeprazole plus aspirin versus rabeprazole plus clopidogrel",{"EARLY_PHASE1":2776,"PHASE1":2778,"PHASE2":2780,"PHASE3":2782,"PHASE4":2784,"NA":2786},{"trials":2777,"activeCount":98},[],{"trials":2779,"activeCount":98},[],{"trials":2781,"activeCount":98},[],{"trials":2783,"activeCount":98},[],{"trials":2785,"activeCount":98},[],{"trials":2787,"activeCount":98},[2788],{"nctId":2789,"briefTitle":2790,"status":404,"phases":2791,"primaryCompletion":1255,"completion":1255,"start":649,"enrollment":395,"conditions":2792,"interventions":2795},"NCT01037491","Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets",[90],[2793,2794],"Gastric Ulcer","Duodenal Ulcer",[2774],{"intervention":2797,"totalTrials":94,"cells":2798},"glucose water",{"EARLY_PHASE1":2799,"PHASE1":2801,"PHASE2":2803,"PHASE3":2805,"PHASE4":2807,"NA":2809},{"trials":2800,"activeCount":98},[],{"trials":2802,"activeCount":98},[],{"trials":2804,"activeCount":98},[],{"trials":2806,"activeCount":98},[],{"trials":2808,"activeCount":98},[],{"trials":2810,"activeCount":98},[2811],{"nctId":2812,"briefTitle":2813,"status":404,"phases":2814,"primaryCompletion":2815,"completion":2815,"start":2300,"enrollment":382,"conditions":2816,"interventions":2817},"NCT03690232","Intraarticular Glucose Versus Hyaluronic Acid Injection for Knee Osteoarthrosis",[90],"2020-06-01",[2291],[2797,2818],"hyaluronic aicd",{"intervention":2818,"totalTrials":94,"cells":2820},{"EARLY_PHASE1":2821,"PHASE1":2823,"PHASE2":2825,"PHASE3":2827,"PHASE4":2829,"NA":2831},{"trials":2822,"activeCount":98},[],{"trials":2824,"activeCount":98},[],{"trials":2826,"activeCount":98},[],{"trials":2828,"activeCount":98},[],{"trials":2830,"activeCount":98},[],{"trials":2832,"activeCount":98},[2833],{"nctId":2812,"briefTitle":2813,"status":404,"phases":2834,"primaryCompletion":2815,"completion":2815,"start":2300,"enrollment":382,"conditions":2835,"interventions":2836},[90],[2291],[2797,2818],{"intervention":2838,"totalTrials":94,"cells":2839},"suprascapular nerve block",{"EARLY_PHASE1":2840,"PHASE1":2842,"PHASE2":2844,"PHASE3":2846,"PHASE4":2848,"NA":2850},{"trials":2841,"activeCount":98},[],{"trials":2843,"activeCount":98},[],{"trials":2845,"activeCount":98},[],{"trials":2847,"activeCount":98},[],{"trials":2849,"activeCount":98},[],{"trials":2851,"activeCount":98},[2852],{"nctId":2853,"briefTitle":2854,"status":404,"phases":2855,"primaryCompletion":2036,"start":2109,"enrollment":165,"conditions":2856,"interventions":2858},"NCT02776865","Does Ultrasound-guided Suprascapular Nerve Block Provide Additional Benefit Over Traditional Rehabilitation Program for Patients With Chronic Shoulder Pain",[90],[2857],"Suprascapular Nerve Block",[2838],{"intervention":2860,"totalTrials":94,"cells":2861},"Gefitinib",{"EARLY_PHASE1":2862,"PHASE1":2864,"PHASE2":2866,"PHASE3":2868,"PHASE4":2870,"NA":2872},{"trials":2863,"activeCount":98},[],{"trials":2865,"activeCount":98},[],{"trials":2867,"activeCount":98},[],{"trials":2869,"activeCount":98},[],{"trials":2871,"activeCount":98},[],{"trials":2873,"activeCount":98},[2874],{"nctId":2875,"briefTitle":2876,"status":230,"phases":2877,"primaryCompletion":2878,"completion":2878,"start":2879,"enrollment":382,"conditions":2880,"interventions":2882},"NCT02740894","Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?",[],"2016-04","2016-02",[2881],"Is Targeted Therapy Increasing Survival Inoperable Nonsmall Cell Lung Cancer With Spinal Metastasis ?",[2860],{"intervention":2884,"totalTrials":94,"cells":2885},"Intensive glycemic control",{"EARLY_PHASE1":2886,"PHASE1":2888,"PHASE2":2890,"PHASE3":2892,"PHASE4":2894,"NA":2896},{"trials":2887,"activeCount":98},[],{"trials":2889,"activeCount":98},[],{"trials":2891,"activeCount":98},[],{"trials":2893,"activeCount":98},[],{"trials":2895,"activeCount":98},[],{"trials":2897,"activeCount":98},[2898],{"nctId":2899,"briefTitle":2900,"status":404,"phases":2901,"primaryCompletion":741,"completion":1913,"start":2135,"enrollment":2902,"conditions":2903,"interventions":2904},"NCT00850798","The Benefits of Intensive Glycemic Control in Elderly Patients With Type 2 Diabetes",[90],208,[18],[2884,2905],"Conservative glycemic control",{"intervention":2905,"totalTrials":94,"cells":2907},{"EARLY_PHASE1":2908,"PHASE1":2910,"PHASE2":2912,"PHASE3":2914,"PHASE4":2916,"NA":2918},{"trials":2909,"activeCount":98},[],{"trials":2911,"activeCount":98},[],{"trials":2913,"activeCount":98},[],{"trials":2915,"activeCount":98},[],{"trials":2917,"activeCount":98},[],{"trials":2919,"activeCount":98},[2920],{"nctId":2899,"briefTitle":2900,"status":404,"phases":2921,"primaryCompletion":741,"completion":1913,"start":2135,"enrollment":2902,"conditions":2922,"interventions":2923},[90],[18],[2884,2905],{"intervention":2925,"totalTrials":94,"cells":2926},"Sugammadex",{"EARLY_PHASE1":2927,"PHASE1":2929,"PHASE2":2931,"PHASE3":2933,"PHASE4":2935,"NA":2937},{"trials":2928,"activeCount":98},[],{"trials":2930,"activeCount":98},[],{"trials":2932,"activeCount":98},[],{"trials":2934,"activeCount":98},[],{"trials":2936,"activeCount":98},[],{"trials":2938,"activeCount":98},[2939],{"nctId":2940,"briefTitle":2941,"status":404,"phases":2942,"primaryCompletion":2943,"completion":2944,"start":2945,"enrollment":382,"conditions":2946,"interventions":2948},"NCT04161508","Enhanced Recovery After Surgery for Anterior Cervcial Spine Surgeries in Elderly Patients",[90],"2021-12-20","2022-12-20","2019-12-20",[2947],"Other Fusion of Spine, Cervical Region",[2925,2949],"Neostigmine",{"intervention":2949,"totalTrials":94,"cells":2951},{"EARLY_PHASE1":2952,"PHASE1":2954,"PHASE2":2956,"PHASE3":2958,"PHASE4":2960,"NA":2962},{"trials":2953,"activeCount":98},[],{"trials":2955,"activeCount":98},[],{"trials":2957,"activeCount":98},[],{"trials":2959,"activeCount":98},[],{"trials":2961,"activeCount":98},[],{"trials":2963,"activeCount":98},[2964],{"nctId":2940,"briefTitle":2941,"status":404,"phases":2965,"primaryCompletion":2943,"completion":2944,"start":2945,"enrollment":382,"conditions":2966,"interventions":2967},[90],[2947],[2925,2949],{"intervention":414,"totalTrials":94,"cells":2969},{"EARLY_PHASE1":2970,"PHASE1":2972,"PHASE2":2974,"PHASE3":2976,"PHASE4":2978,"NA":2980},{"trials":2971,"activeCount":98},[],{"trials":2973,"activeCount":98},[],{"trials":2975,"activeCount":98},[],{"trials":2977,"activeCount":98},[],{"trials":2979,"activeCount":98},[],{"trials":2981,"activeCount":98},[2982],{"nctId":402,"briefTitle":403,"status":404,"phases":2983,"primaryCompletion":406,"completion":407,"start":408,"enrollment":165,"conditions":2984,"interventions":2985},[],[30,410,411],[64,413,414],{"intervention":2987,"totalTrials":94,"cells":2988},"Triamcinolone (Shincort) injection to rotator interval",{"EARLY_PHASE1":2989,"PHASE1":2991,"PHASE2":2993,"PHASE3":2995,"PHASE4":2997,"NA":2999},{"trials":2990,"activeCount":98},[],{"trials":2992,"activeCount":98},[],{"trials":2994,"activeCount":98},[],{"trials":2996,"activeCount":98},[],{"trials":2998,"activeCount":98},[],{"trials":3000,"activeCount":98},[3001],{"nctId":3002,"briefTitle":3003,"status":230,"phases":3004,"primaryCompletion":3005,"completion":3006,"start":3007,"enrollment":3008,"conditions":3009,"interventions":3010},"NCT03678038","Comparison of Rotator Interval Injection Versus Intraarticular Hydrodilatation in Frozen Shoulder",[90],"2021-01-15","2021-03-15","2018-09-28",64,[23],[2987,3011],"Triamcinolone (Shincort) injection to posterior glenuhumeral recess",{"intervention":3011,"totalTrials":94,"cells":3013},{"EARLY_PHASE1":3014,"PHASE1":3016,"PHASE2":3018,"PHASE3":3020,"PHASE4":3022,"NA":3024},{"trials":3015,"activeCount":98},[],{"trials":3017,"activeCount":98},[],{"trials":3019,"activeCount":98},[],{"trials":3021,"activeCount":98},[],{"trials":3023,"activeCount":98},[],{"trials":3025,"activeCount":98},[3026],{"nctId":3002,"briefTitle":3003,"status":230,"phases":3027,"primaryCompletion":3005,"completion":3006,"start":3007,"enrollment":3008,"conditions":3028,"interventions":3029},[90],[23],[2987,3011],{"intervention":2591,"totalTrials":94,"cells":3031},{"EARLY_PHASE1":3032,"PHASE1":3034,"PHASE2":3036,"PHASE3":3038,"PHASE4":3040,"NA":3042},{"trials":3033,"activeCount":98},[],{"trials":3035,"activeCount":98},[],{"trials":3037,"activeCount":98},[],{"trials":3039,"activeCount":98},[],{"trials":3041,"activeCount":98},[],{"trials":3043,"activeCount":98},[3044],{"nctId":2583,"briefTitle":2584,"status":404,"phases":3045,"primaryCompletion":2586,"completion":779,"start":2587,"enrollment":139,"conditions":3046,"interventions":3047},[90],[2589],[2591,2568],{"intervention":2601,"totalTrials":94,"cells":3049},{"EARLY_PHASE1":3050,"PHASE1":3052,"PHASE2":3054,"PHASE3":3056,"PHASE4":3058,"NA":3060},{"trials":3051,"activeCount":98},[],{"trials":3053,"activeCount":98},[],{"trials":3055,"activeCount":98},[],{"trials":3057,"activeCount":98},[],{"trials":3059,"activeCount":98},[],{"trials":3061,"activeCount":98},[3062],{"nctId":2593,"briefTitle":2594,"status":404,"phases":3063,"primaryCompletion":1255,"completion":1255,"start":2596,"enrollment":2597,"conditions":3064,"interventions":3065},[90],[1873,2599],[2568,2601],{"intervention":3067,"totalTrials":94,"cells":3068},"Leuprorelin",{"EARLY_PHASE1":3069,"PHASE1":3071,"PHASE2":3073,"PHASE3":3075,"PHASE4":3077,"NA":3079},{"trials":3070,"activeCount":98},[],{"trials":3072,"activeCount":98},[],{"trials":3074,"activeCount":98},[],{"trials":3076,"activeCount":98},[],{"trials":3078,"activeCount":98},[],{"trials":3080,"activeCount":98},[3081],{"nctId":3082,"briefTitle":3083,"status":230,"phases":3084,"primaryCompletion":3085,"completion":3086,"start":3087,"enrollment":3088,"conditions":3089,"interventions":3091},"NCT03778359","Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis",[],"2015-12-31","2018-10-18","2005-01-01",5000,[1846,3090],"Adenomyosis",[3067,3092,3093],"Dienogest","Progestins",{"intervention":3092,"totalTrials":94,"cells":3095},{"EARLY_PHASE1":3096,"PHASE1":3098,"PHASE2":3100,"PHASE3":3102,"PHASE4":3104,"NA":3106},{"trials":3097,"activeCount":98},[],{"trials":3099,"activeCount":98},[],{"trials":3101,"activeCount":98},[],{"trials":3103,"activeCount":98},[],{"trials":3105,"activeCount":98},[],{"trials":3107,"activeCount":98},[3108],{"nctId":3082,"briefTitle":3083,"status":230,"phases":3109,"primaryCompletion":3085,"completion":3086,"start":3087,"enrollment":3088,"conditions":3110,"interventions":3111},[],[1846,3090],[3067,3092,3093],{"intervention":3093,"totalTrials":94,"cells":3113},{"EARLY_PHASE1":3114,"PHASE1":3116,"PHASE2":3118,"PHASE3":3120,"PHASE4":3122,"NA":3124},{"trials":3115,"activeCount":98},[],{"trials":3117,"activeCount":98},[],{"trials":3119,"activeCount":98},[],{"trials":3121,"activeCount":98},[],{"trials":3123,"activeCount":98},[],{"trials":3125,"activeCount":98},[3126],{"nctId":3082,"briefTitle":3083,"status":230,"phases":3127,"primaryCompletion":3085,"completion":3086,"start":3087,"enrollment":3088,"conditions":3128,"interventions":3129},[],[1846,3090],[3067,3092,3093],{"intervention":3131,"totalTrials":94,"cells":3132},"steroid hydrodilatation",{"EARLY_PHASE1":3133,"PHASE1":3135,"PHASE2":3137,"PHASE3":3139,"PHASE4":3141,"NA":3143},{"trials":3134,"activeCount":98},[],{"trials":3136,"activeCount":98},[],{"trials":3138,"activeCount":98},[],{"trials":3140,"activeCount":98},[],{"trials":3142,"activeCount":98},[],{"trials":3144,"activeCount":98},[3145],{"nctId":3146,"briefTitle":3147,"status":404,"phases":3148,"primaryCompletion":3149,"completion":3149,"start":3150,"enrollment":3151,"conditions":3152,"interventions":3154},"NCT05921539","Does Axillary Nerve and Inferior Capsule Release Add Extra Benefit in Treating Patients With Adhesive Capsulitis",[90],"2025-03-01","2021-12-01",72,[3153],"Adhesive Capsulitis of Shoulder",[3131,3155],"axillary nerve",{"intervention":3155,"totalTrials":94,"cells":3157},{"EARLY_PHASE1":3158,"PHASE1":3160,"PHASE2":3162,"PHASE3":3164,"PHASE4":3166,"NA":3168},{"trials":3159,"activeCount":98},[],{"trials":3161,"activeCount":98},[],{"trials":3163,"activeCount":98},[],{"trials":3165,"activeCount":98},[],{"trials":3167,"activeCount":98},[],{"trials":3169,"activeCount":98},[3170],{"nctId":3146,"briefTitle":3147,"status":404,"phases":3171,"primaryCompletion":3149,"completion":3149,"start":3150,"enrollment":3151,"conditions":3172,"interventions":3173},[90],[3153],[3131,3155],{"intervention":3175,"totalTrials":94,"cells":3176},"usual care",{"EARLY_PHASE1":3177,"PHASE1":3179,"PHASE2":3181,"PHASE3":3183,"PHASE4":3185,"NA":3187},{"trials":3178,"activeCount":98},[],{"trials":3180,"activeCount":98},[],{"trials":3182,"activeCount":98},[],{"trials":3184,"activeCount":98},[],{"trials":3186,"activeCount":98},[],{"trials":3188,"activeCount":98},[3189],{"nctId":3190,"briefTitle":3191,"status":404,"phases":3192,"primaryCompletion":3193,"completion":3194,"start":2253,"enrollment":3195,"conditions":3196,"interventions":3198},"NCT02556073","ICS\u002FLABA Combination With Integrated Dose Counter and Smartphone APP to Improve Asthma Control",[90],"2016-08","2016-12",112,[3197],"Asthma",[3175],{"intervention":2530,"totalTrials":94,"cells":3200},{"EARLY_PHASE1":3201,"PHASE1":3203,"PHASE2":3205,"PHASE3":3207,"PHASE4":3209,"NA":3211},{"trials":3202,"activeCount":98},[],{"trials":3204,"activeCount":98},[],{"trials":3206,"activeCount":98},[],{"trials":3208,"activeCount":98},[],{"trials":3210,"activeCount":98},[],{"trials":3212,"activeCount":98},[3213],{"nctId":2524,"briefTitle":2525,"status":230,"phases":3214,"primaryCompletion":1480,"completion":648,"start":2527,"enrollment":165,"conditions":3215,"interventions":3216},[90],[18],[783,2530],{"intervention":3218,"totalTrials":94,"cells":3219},"Periarticular",{"EARLY_PHASE1":3220,"PHASE1":3222,"PHASE2":3224,"PHASE3":3226,"PHASE4":3228,"NA":3230},{"trials":3221,"activeCount":98},[],{"trials":3223,"activeCount":98},[],{"trials":3225,"activeCount":98},[],{"trials":3227,"activeCount":98},[],{"trials":3229,"activeCount":98},[],{"trials":3231,"activeCount":98},[3232],{"nctId":3233,"briefTitle":3234,"status":230,"phases":3235,"primaryCompletion":3236,"completion":3237,"start":3238,"enrollment":3239,"conditions":3240,"interventions":3243},"NCT06630520","Intraoperative Periarticular Injection in Arthroscopic Anterior Cruciate Ligament Reconstruction Surgery",[90],"2022-06-20","2023-06-20","2022-03-20",288,[3241,3242],"Anterior Cruciate Ligament (ACL) Tear","Arthroscopic Anterior Cruciate Ligament Reconstruction",[3218],{"intervention":3245,"totalTrials":94,"cells":3246},"Regorafenib",{"EARLY_PHASE1":3247,"PHASE1":3249,"PHASE2":3251,"PHASE3":3253,"PHASE4":3255,"NA":3257},{"trials":3248,"activeCount":98},[],{"trials":3250,"activeCount":98},[],{"trials":3252,"activeCount":98},[],{"trials":3254,"activeCount":98},[],{"trials":3256,"activeCount":98},[],{"trials":3258,"activeCount":98},[3259],{"nctId":3260,"briefTitle":3261,"status":230,"phases":3262,"primaryCompletion":3263,"completion":3263,"start":2768,"enrollment":3264,"conditions":3265,"interventions":3267},"NCT03829852","Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients",[],"2020-12-08",716,[3266],"Metastatic Colorectal Cancer",[3245],{"intervention":2440,"totalTrials":94,"cells":3269},{"EARLY_PHASE1":3270,"PHASE1":3272,"PHASE2":3274,"PHASE3":3276,"PHASE4":3278,"NA":3280},{"trials":3271,"activeCount":98},[],{"trials":3273,"activeCount":98},[],{"trials":3275,"activeCount":98},[],{"trials":3277,"activeCount":98},[],{"trials":3279,"activeCount":98},[],{"trials":3281,"activeCount":98},[3282],{"nctId":2431,"briefTitle":2432,"status":404,"phases":3283,"primaryCompletion":2434,"completion":2435,"start":2436,"enrollment":2437,"conditions":3284,"interventions":3285},[90],[23],[2408,2440,2441,2442],{"intervention":2441,"totalTrials":94,"cells":3287},{"EARLY_PHASE1":3288,"PHASE1":3290,"PHASE2":3292,"PHASE3":3294,"PHASE4":3296,"NA":3298},{"trials":3289,"activeCount":98},[],{"trials":3291,"activeCount":98},[],{"trials":3293,"activeCount":98},[],{"trials":3295,"activeCount":98},[],{"trials":3297,"activeCount":98},[],{"trials":3299,"activeCount":98},[3300],{"nctId":2431,"briefTitle":2432,"status":404,"phases":3301,"primaryCompletion":2434,"completion":2435,"start":2436,"enrollment":2437,"conditions":3302,"interventions":3303},[90],[23],[2408,2440,2441,2442],{"intervention":2442,"totalTrials":94,"cells":3305},{"EARLY_PHASE1":3306,"PHASE1":3308,"PHASE2":3310,"PHASE3":3312,"PHASE4":3314,"NA":3316},{"trials":3307,"activeCount":98},[],{"trials":3309,"activeCount":98},[],{"trials":3311,"activeCount":98},[],{"trials":3313,"activeCount":98},[],{"trials":3315,"activeCount":98},[],{"trials":3317,"activeCount":98},[3318],{"nctId":2431,"briefTitle":2432,"status":404,"phases":3319,"primaryCompletion":2434,"completion":2435,"start":2436,"enrollment":2437,"conditions":3320,"interventions":3321},[90],[23],[2408,2440,2441,2442]]